SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/09/23 Evolutionary Genomics, Inc. 10-K 12/31/22 58:3.3M Edgar Filing LLC/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 675K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 18K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 18K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 15K 5: EX-32.2 Certification -- §906 - SOA'02 HTML 15K 11: R1 Cover HTML 76K 12: R2 Consolidated Balance Sheets HTML 99K 13: R3 Consolidated Balance Sheets (Parenthetical) HTML 40K 14: R4 Consolidated Statements of Operations HTML 95K 15: R5 Condensed and Consolidated Statement of HTML 50K Stockholders' Deficit 16: R6 Condensed and Consolidated Statements of Cash HTML 72K Flows 17: R7 Business Activity HTML 22K 18: R8 Summary of Significant Accounting Policies HTML 36K 19: R9 New Accounting Standards HTML 29K 20: R10 Property and Equipment HTML 31K 21: R11 Intangible Assets HTML 36K 22: R12 Income Taxes HTML 44K 23: R13 Notes Payable HTML 32K 24: R14 Stockholders? Equity HTML 32K 25: R15 Stock-Based Compensation HTML 64K 26: R16 Commitments and Contingencies HTML 26K 27: R17 Related Parties and Transactions HTML 21K 28: R18 Concentrations HTML 19K 29: R19 Liquidity and Going Concern HTML 23K 30: R20 Subsequent Event HTML 19K 31: R21 Summary of Significant Accounting Policies HTML 62K (Policies) 32: R22 Property and Equipment (Tables) HTML 28K 33: R23 Intangible Assets (Tables) HTML 35K 34: R24 Income Taxes (Tables) HTML 37K 35: R25 Stock-Based Compensation (Tables) HTML 58K 36: R26 Summary of Significant Accounting Policies HTML 29K (Details Narrative) 37: R27 Property and Equipment (Details) HTML 30K 38: R28 Property and Equipment (Details Narrative) HTML 18K 39: R29 Intangible Assets (Details) HTML 27K 40: R30 Intangible Assets (Details 1) HTML 30K 41: R31 Intangible Assets (Details Narrative) HTML 23K 42: R32 Income Taxes (Details) HTML 36K 43: R33 Income Taxes (Details 1) HTML 40K 44: R34 Income Taxes (Details Narrative) HTML 26K 45: R35 Notes Payable (Details Narrative) HTML 59K 46: R36 Stockholders? Equity (Details Narrative) HTML 43K 47: R37 Stock-Based Compensation (Details) HTML 25K 48: R38 Stock-Based Compensation (Details 1) HTML 53K 49: R39 Stock-Based Compensation (Details Narrative) HTML 29K 50: R40 Commitments and Contingencies (Details Narrative) HTML 37K 51: R41 Related Parties and Transactions (Details HTML 21K Narrative) 52: R42 Liquidity and Going Concern (Details Narrative) HTML 32K 53: R43 Subsequent Event (Details Narrative) HTML 23K 56: XML IDEA XML File -- Filing Summary XML 98K 54: XML XBRL Instance -- fnam_10k_htm XML 548K 55: EXCEL IDEA Workbook of Financial Reports XLSX 72K 7: EX-101.CAL XBRL Calculations -- fnam-20221231_cal XML 102K 8: EX-101.DEF XBRL Definitions -- fnam-20221231_def XML 243K 9: EX-101.LAB XBRL Labels -- fnam-20221231_lab XML 632K 10: EX-101.PRE XBRL Presentations -- fnam-20221231_pre XML 480K 6: EX-101.SCH XBRL Schema -- fnam-20221231 XSD 98K 57: JSON XBRL Instance as JSON Data -- MetaLinks 273± 402K 58: ZIP XBRL Zipped Folder -- 0001553350-23-000160-xbrl Zip 183K
<?xml version="1.0" encoding="windows-1252"?> | |||||||||||||||||||||
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:fnam="http://evolutionarygenomicsinc.com/20221231" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"> | |||||||||||||||||||||
<link:schemaRef xlink:href="fnam-20221231.xsd" xlink:type="simple"/> | |||||||||||||||||||||
<context id="From2022-01-01to2022-12-31"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2022-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2022-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2022-06-30"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2022-06-30 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2023-03-01"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2023-03-01 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2022-12-31"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2022-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2021-12-31"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2021-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2022-12-31_custom_SeriesA1PreferredStockMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> fnam:SeriesA1PreferredStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2022-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2021-12-31_custom_SeriesA1PreferredStockMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> fnam:SeriesA1PreferredStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2021-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2022-12-31_custom_SeriesA2PreferredStockMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> fnam:SeriesA2PreferredStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2022-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2021-12-31_custom_SeriesA2PreferredStockMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> fnam:SeriesA2PreferredStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2021-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2022-12-31_us-gaap_SeriesAPreferredStockMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:SeriesAPreferredStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2022-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:SeriesAPreferredStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2021-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2021-01-012021-12-31"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2021-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2021-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2021-12-31_us-gaap_CommonStockMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2021-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2021-12-31_custom_PreferredDividendMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> fnam:PreferredDividendMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2021-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2021-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2021-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2020-12-31_us-gaap_CommonStockMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2020-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2020-12-31_custom_PreferredDividendMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> fnam:PreferredDividendMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2020-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2020-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2020-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2020-12-31"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2020-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2022-01-012022-12-31_us-gaap_CommonStockMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2022-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2022-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2022-01-012022-12-31_custom_PreferredDividendMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> fnam:PreferredDividendMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2022-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2022-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2022-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2022-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2022-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2022-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2021-01-012021-12-31_us-gaap_CommonStockMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2021-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2021-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2021-01-012021-12-31_custom_PreferredDividendMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> fnam:PreferredDividendMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2021-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2021-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2021-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2021-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2021-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2021-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2022-12-31_us-gaap_CommonStockMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2022-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2022-12-31_custom_PreferredDividendMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> fnam:PreferredDividendMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2022-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2022-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2022-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2023-01-012023-03-09_us-gaap_SubsequentEventMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2023-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2023-03-09 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2022-01-012022-12-31_us-gaap_ConvertibleDebtSecuritiesMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:ConvertibleDebtSecuritiesMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2022-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2022-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2022-01-012022-12-31_us-gaap_OptionMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis"> us-gaap:OptionMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2022-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2022-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2021-01-012021-12-31_us-gaap_ConvertibleDebtSecuritiesMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:ConvertibleDebtSecuritiesMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2021-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2021-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2021-01-012021-12-31_us-gaap_OptionMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis"> us-gaap:OptionMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2021-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2021-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2022-12-31_us-gaap_EquipmentMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:EquipmentMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2022-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2021-12-31_us-gaap_EquipmentMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:EquipmentMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2021-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2022-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:SoftwareAndSoftwareDevelopmentCostsMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2022-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2021-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:SoftwareAndSoftwareDevelopmentCostsMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2021-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2022-12-31_us-gaap_FurnitureAndFixturesMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:FurnitureAndFixturesMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2022-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:FurnitureAndFixturesMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2021-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2022-12-31_us-gaap_InProcessResearchAndDevelopmentMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:InProcessResearchAndDevelopmentMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2022-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2021-12-31_us-gaap_InProcessResearchAndDevelopmentMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:InProcessResearchAndDevelopmentMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2021-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2022-12-31_us-gaap_PatentsMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:PatentsMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2022-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2021-12-31_us-gaap_PatentsMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:PatentsMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2021-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2022-01-012022-12-31_us-gaap_PatentsMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:PatentsMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2022-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2022-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2021-01-012021-12-31_us-gaap_PatentsMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> us-gaap:PatentsMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2021-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2021-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2021-02-012021-02-22_custom_SBAPaycheckProtectionProgramMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> fnam:SBAPaycheckProtectionProgramMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2021-02-01 </startDate> | |||||||||||||||||||||
<endDate> 2021-02-22 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2020-06-042020-06-05_custom_EIDLProgramMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> fnam:EIDLProgramMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2020-06-04 </startDate> | |||||||||||||||||||||
<endDate> 2020-06-05 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2021-07-012021-07-20_custom_EconomicInjuryDisasterLoanMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> fnam:EconomicInjuryDisasterLoanMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2021-07-01 </startDate> | |||||||||||||||||||||
<endDate> 2021-07-20 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2021-07-012021-07-14_custom_EIDLProgramMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> fnam:EIDLProgramMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2021-07-01 </startDate> | |||||||||||||||||||||
<endDate> 2021-07-14 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2020-06-05_custom_EIDLProgramMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> fnam:EIDLProgramMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2020-06-05 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2022-12-31_custom_EIDLProgramMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> fnam:EIDLProgramMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2022-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2020-08-19_custom_DCADoleMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> fnam:DCADoleMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2020-08-19 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2020-08-19_custom_ResearchAgreementUniversityOfWisconsinMadisonMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> fnam:ResearchAgreementUniversityOfWisconsinMadisonMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2020-08-19 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2020-08-26_custom_DCADoleMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> fnam:DCADoleMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2020-08-26 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2021-07-28_custom_DCADoleMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> fnam:DCADoleMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2021-07-28 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2020-12-29_custom_DCADoleMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> fnam:DCADoleMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2020-12-29 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2021-09-29_custom_DCADoleMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> fnam:DCADoleMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2021-09-29 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2015-10-19"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2015-10-19 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2015-10-19_us-gaap_ConvertiblePreferredStockMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:ConvertiblePreferredStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2015-10-19 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2015-10-19_custom_ConvertiblePreferredStockSeriesA2Member"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> fnam:ConvertiblePreferredStockSeriesA2Member </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2015-10-19 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2022-01-012022-12-31_custom_ConvertiblePreferredStockSeriesA2Member"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> fnam:ConvertiblePreferredStockSeriesA2Member </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2022-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2022-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2022-01-012022-12-31_us-gaap_ConvertiblePreferredStockMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:ConvertiblePreferredStockMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2022-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2022-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2020-09-012020-09-18_custom_StandardResearchAgreementMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> fnam:StandardResearchAgreementMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2020-09-01 </startDate> | |||||||||||||||||||||
<endDate> 2020-09-18 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2022-01-012022-12-31_custom_ServiceAgreementMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> fnam:ServiceAgreementMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2022-01-01 </startDate> | |||||||||||||||||||||
<endDate> 2022-12-31 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="From2022-04-012022-04-18_custom_ServiceAgreementMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> fnam:ServiceAgreementMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<startDate> 2022-04-01 </startDate> | |||||||||||||||||||||
<endDate> 2022-04-18 </endDate> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<context id="AsOf2022-12-31_srt_ChiefExecutiveOfficerMember"> | |||||||||||||||||||||
<entity> | |||||||||||||||||||||
<identifier scheme="http://www.sec.gov/CIK"> 0000884363 </identifier> | |||||||||||||||||||||
<segment> | |||||||||||||||||||||
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> srt:ChiefExecutiveOfficerMember </xbrldi:explicitMember> | |||||||||||||||||||||
</segment> | |||||||||||||||||||||
</entity> | |||||||||||||||||||||
<period> | |||||||||||||||||||||
<instant> 2022-12-31 </instant> | |||||||||||||||||||||
</period> | |||||||||||||||||||||
</context> | |||||||||||||||||||||
<unit id="USD"> | |||||||||||||||||||||
<measure> iso4217:USD </measure> | |||||||||||||||||||||
</unit> | |||||||||||||||||||||
<unit id="Shares"> | |||||||||||||||||||||
<measure> shares </measure> | |||||||||||||||||||||
</unit> | |||||||||||||||||||||
<unit id="USDPShares"> | |||||||||||||||||||||
<divide> | |||||||||||||||||||||
<unitNumerator> | |||||||||||||||||||||
<measure> iso4217:USD </measure> | |||||||||||||||||||||
</unitNumerator> | |||||||||||||||||||||
<unitDenominator> | |||||||||||||||||||||
<measure> shares </measure> | |||||||||||||||||||||
</unitDenominator> | |||||||||||||||||||||
</divide> | |||||||||||||||||||||
</unit> | |||||||||||||||||||||
<unit id="Pure"> | |||||||||||||||||||||
<measure> pure </measure> | |||||||||||||||||||||
</unit> | |||||||||||||||||||||
<dei:EntityCentralIndexKey contextRef="From2022-01-01to2022-12-31"> 0000884363 </dei:EntityCentralIndexKey> | |||||||||||||||||||||
<dei:AmendmentFlag contextRef="From2022-01-01to2022-12-31"> false </dei:AmendmentFlag> | |||||||||||||||||||||
<dei:DocumentFiscalYearFocus contextRef="From2022-01-01to2022-12-31"> 2022 </dei:DocumentFiscalYearFocus> | |||||||||||||||||||||
<dei:DocumentFiscalPeriodFocus contextRef="From2022-01-01to2022-12-31"> FY </dei:DocumentFiscalPeriodFocus> | |||||||||||||||||||||
<us-gaap:IncomeTaxReceivable contextRef="AsOf2021-12-31" id="xdx2ixbrl0057" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:Revenues contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0189" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:Revenues contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0190" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<fnam:EmployeesRetentionCredit contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0217" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0219" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:IncomeTaxExpenseBenefit contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0228" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:IncomeTaxExpenseBenefit contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0229" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-01-012022-12-31_custom_PreferredDividendMember" id="xdx2ixbrl0261" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0263" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<fnam:StockIssuedDuringPeriodValueStockOptionExercised contextRef="From2022-01-012022-12-31_custom_PreferredDividendMember" id="xdx2ixbrl0269" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<fnam:StockIssuedDuringPeriodValueStockOptionExercised contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0271" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<fnam:StockIssuedDuringPeriodValueStockOptionExercised contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0272" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0276" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2022-01-012022-12-31_custom_PreferredDividendMember" id="xdx2ixbrl0277" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0279" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0282" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0285" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0286" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:ProfitLoss contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0288" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:ProfitLoss contextRef="From2022-01-012022-12-31_custom_PreferredDividendMember" id="xdx2ixbrl0289" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:ProfitLoss contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0290" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0310" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2021-01-012021-12-31_custom_PreferredDividendMember" id="xdx2ixbrl0311" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0313" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0316" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0319" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0320" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:ProfitLoss contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0322" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:ProfitLoss contextRef="From2021-01-012021-12-31_custom_PreferredDividendMember" id="xdx2ixbrl0323" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:ProfitLoss contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0324" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0354" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<fnam:EmployeesRetentionCredit contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0358" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0372" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0373" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0379" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0382" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:ProceedsFromNotesPayable contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0384" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<fnam:NontaxableForgivenessOfPppAndEidlLoans contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0539" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0554" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0555" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits contextRef="AsOf2021-12-31" id="xdx2ixbrl0569" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:DeferredTaxLiabilities contextRef="AsOf2022-12-31" id="xdx2ixbrl0592" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:DeferredTaxLiabilities contextRef="AsOf2021-12-31" id="xdx2ixbrl0593" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0709" unitRef="Shares" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0711" unitRef="USDPShares" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0713" unitRef="Shares" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0715" unitRef="USDPShares" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0717" unitRef="Shares" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0719" unitRef="USDPShares" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0743" unitRef="Shares" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0745" unitRef="USDPShares" xsi:nil="true"/> | |||||||||||||||||||||
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2022-12-31" id="xdx2ixbrl0759" unitRef="USD" xsi:nil="true"/> | |||||||||||||||||||||
<dei:DocumentType contextRef="From2022-01-01to2022-12-31"> 10-K </dei:DocumentType> | |||||||||||||||||||||
<dei:DocumentAnnualReport contextRef="From2022-01-01to2022-12-31"> true </dei:DocumentAnnualReport> | |||||||||||||||||||||
<dei:DocumentPeriodEndDate contextRef="From2022-01-01to2022-12-31"> 2022-12-31 </dei:DocumentPeriodEndDate> | |||||||||||||||||||||
<dei:CurrentFiscalYearEndDate contextRef="From2022-01-01to2022-12-31"> --12-31 </dei:CurrentFiscalYearEndDate> | |||||||||||||||||||||
<dei:DocumentTransitionReport contextRef="From2022-01-01to2022-12-31"> false </dei:DocumentTransitionReport> | |||||||||||||||||||||
<dei:EntityRegistrantName contextRef="From2022-01-01to2022-12-31"> Evolutionary Genomics, Inc. </dei:EntityRegistrantName> | |||||||||||||||||||||
<dei:EntityIncorporationStateCountryCode contextRef="From2022-01-01to2022-12-31"> NV </dei:EntityIncorporationStateCountryCode> | |||||||||||||||||||||
<dei:EntityFileNumber contextRef="From2022-01-01to2022-12-31"> 000-54129 </dei:EntityFileNumber> | |||||||||||||||||||||
<dei:EntityTaxIdentificationNumber contextRef="From2022-01-01to2022-12-31"> 26-4369698 </dei:EntityTaxIdentificationNumber> | |||||||||||||||||||||
<dei:EntityAddressAddressLine1 contextRef="From2022-01-01to2022-12-31"> 4220 Morning Star Drive </dei:EntityAddressAddressLine1> | |||||||||||||||||||||
<dei:EntityAddressCityOrTown contextRef="From2022-01-01to2022-12-31"> Castle Rock </dei:EntityAddressCityOrTown> | |||||||||||||||||||||
<dei:EntityAddressStateOrProvince contextRef="From2022-01-01to2022-12-31"> CO </dei:EntityAddressStateOrProvince> | |||||||||||||||||||||
<dei:EntityAddressPostalZipCode contextRef="From2022-01-01to2022-12-31"> 80108 </dei:EntityAddressPostalZipCode> | |||||||||||||||||||||
<dei:CityAreaCode contextRef="From2022-01-01to2022-12-31"> (720) </dei:CityAreaCode> | |||||||||||||||||||||
<dei:LocalPhoneNumber contextRef="From2022-01-01to2022-12-31"> 900-8666 </dei:LocalPhoneNumber> | |||||||||||||||||||||
<dei:EntityWellKnownSeasonedIssuer contextRef="From2022-01-01to2022-12-31"> No </dei:EntityWellKnownSeasonedIssuer> | |||||||||||||||||||||
<dei:EntityVoluntaryFilers contextRef="From2022-01-01to2022-12-31"> No </dei:EntityVoluntaryFilers> | |||||||||||||||||||||
<dei:EntityCurrentReportingStatus contextRef="From2022-01-01to2022-12-31"> Yes </dei:EntityCurrentReportingStatus> | |||||||||||||||||||||
<dei:EntityInteractiveDataCurrent contextRef="From2022-01-01to2022-12-31"> Yes </dei:EntityInteractiveDataCurrent> | |||||||||||||||||||||
<dei:EntityFilerCategory contextRef="From2022-01-01to2022-12-31"> Non-accelerated Filer </dei:EntityFilerCategory> | |||||||||||||||||||||
<dei:EntitySmallBusiness contextRef="From2022-01-01to2022-12-31"> true </dei:EntitySmallBusiness> | |||||||||||||||||||||
<dei:EntityEmergingGrowthCompany contextRef="From2022-01-01to2022-12-31"> false </dei:EntityEmergingGrowthCompany> | |||||||||||||||||||||
<dei:EntityShellCompany contextRef="From2022-01-01to2022-12-31"> false </dei:EntityShellCompany> | |||||||||||||||||||||
<dei:EntityPublicFloat contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 3137627 </dei:EntityPublicFloat> | |||||||||||||||||||||
<dei:EntityCommonStockSharesOutstanding contextRef="AsOf2023-03-01" decimals="INF" unitRef="Shares"> 6655232 </dei:EntityCommonStockSharesOutstanding> | |||||||||||||||||||||
<dei:AuditorName contextRef="From2022-01-01to2022-12-31"> Plante & Moran PLLC </dei:AuditorName> | |||||||||||||||||||||
<dei:AuditorLocation contextRef="From2022-01-01to2022-12-31"> Denver, Colorado </dei:AuditorLocation> | |||||||||||||||||||||
<dei:AuditorFirmId contextRef="From2022-01-01to2022-12-31"> 166 </dei:AuditorFirmId> | |||||||||||||||||||||
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 577066 </us-gaap:CashAndCashEquivalentsAtCarryingValue> | |||||||||||||||||||||
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 214009 </us-gaap:CashAndCashEquivalentsAtCarryingValue> | |||||||||||||||||||||
<us-gaap:IncomeTaxReceivable contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 78000 </us-gaap:IncomeTaxReceivable> | |||||||||||||||||||||
<us-gaap:PrepaidExpenseCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 43847 </us-gaap:PrepaidExpenseCurrent> | |||||||||||||||||||||
<us-gaap:PrepaidExpenseCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 41792 </us-gaap:PrepaidExpenseCurrent> | |||||||||||||||||||||
<us-gaap:AssetsCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 698913 </us-gaap:AssetsCurrent> | |||||||||||||||||||||
<us-gaap:AssetsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 255801 </us-gaap:AssetsCurrent> | |||||||||||||||||||||
<us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 3956 </us-gaap:PropertyPlantAndEquipmentNet> | |||||||||||||||||||||
<us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 18698 </us-gaap:PropertyPlantAndEquipmentNet> | |||||||||||||||||||||
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 1650841 </us-gaap:FiniteLivedIntangibleAssetsNet> | |||||||||||||||||||||
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 2657592 </us-gaap:FiniteLivedIntangibleAssetsNet> | |||||||||||||||||||||
<us-gaap:AssetsNoncurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 1654797 </us-gaap:AssetsNoncurrent> | |||||||||||||||||||||
<us-gaap:AssetsNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 2676290 </us-gaap:AssetsNoncurrent> | |||||||||||||||||||||
<us-gaap:Assets contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 2353710 </us-gaap:Assets> | |||||||||||||||||||||
<us-gaap:Assets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 2932091 </us-gaap:Assets> | |||||||||||||||||||||
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 178240 </us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent> | |||||||||||||||||||||
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 18866 </us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent> | |||||||||||||||||||||
<us-gaap:LongTermDebtNoncurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 3743747 </us-gaap:LongTermDebtNoncurrent> | |||||||||||||||||||||
<us-gaap:LongTermDebtNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 3743747 </us-gaap:LongTermDebtNoncurrent> | |||||||||||||||||||||
<us-gaap:Liabilities contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 3921987 </us-gaap:Liabilities> | |||||||||||||||||||||
<us-gaap:Liabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 3762613 </us-gaap:Liabilities> | |||||||||||||||||||||
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2022-12-31" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare> | |||||||||||||||||||||
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2021-12-31" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare> | |||||||||||||||||||||
<us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares"> 20000000 </us-gaap:PreferredStockSharesAuthorized> | |||||||||||||||||||||
<us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares"> 20000000 </us-gaap:PreferredStockSharesAuthorized> | |||||||||||||||||||||
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2022-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare> | |||||||||||||||||||||
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare> | |||||||||||||||||||||
<us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 600000 </us-gaap:PreferredStockSharesAuthorized> | |||||||||||||||||||||
<us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 600000 </us-gaap:PreferredStockSharesAuthorized> | |||||||||||||||||||||
<us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 577063 </us-gaap:PreferredStockSharesIssued> | |||||||||||||||||||||
<us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 577063 </us-gaap:PreferredStockSharesOutstanding> | |||||||||||||||||||||
<us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 577063 </us-gaap:PreferredStockSharesIssued> | |||||||||||||||||||||
<us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 577063 </us-gaap:PreferredStockSharesOutstanding> | |||||||||||||||||||||
<us-gaap:PreferredStockLiquidationPreferenceValue contextRef="AsOf2022-12-31_us-gaap_SeriesAPreferredStockMember" decimals="0" unitRef="USD"> 4679662 </us-gaap:PreferredStockLiquidationPreferenceValue> | |||||||||||||||||||||
<us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2022-12-31_custom_SeriesA1PreferredStockMember" decimals="0" unitRef="USD"> 3029579 </us-gaap:TemporaryEquityCarryingAmountAttributableToParent> | |||||||||||||||||||||
<us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2021-12-31_custom_SeriesA1PreferredStockMember" decimals="0" unitRef="USD"> 3029579 </us-gaap:TemporaryEquityCarryingAmountAttributableToParent> | |||||||||||||||||||||
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2022-12-31_custom_SeriesA2PreferredStockMember" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare> | |||||||||||||||||||||
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2021-12-31_custom_SeriesA2PreferredStockMember" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare> | |||||||||||||||||||||
<us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-12-31_custom_SeriesA2PreferredStockMember" decimals="INF" unitRef="Shares"> 200000 </us-gaap:PreferredStockSharesAuthorized> | |||||||||||||||||||||
<us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31_custom_SeriesA2PreferredStockMember" decimals="INF" unitRef="Shares"> 200000 </us-gaap:PreferredStockSharesAuthorized> | |||||||||||||||||||||
<us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-12-31_custom_SeriesA2PreferredStockMember" decimals="INF" unitRef="Shares"> 189337 </us-gaap:PreferredStockSharesIssued> | |||||||||||||||||||||
<us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-12-31_custom_SeriesA2PreferredStockMember" decimals="INF" unitRef="Shares"> 189337 </us-gaap:PreferredStockSharesOutstanding> | |||||||||||||||||||||
<us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31_custom_SeriesA2PreferredStockMember" decimals="INF" unitRef="Shares"> 102860 </us-gaap:PreferredStockSharesIssued> | |||||||||||||||||||||
<us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-12-31_custom_SeriesA2PreferredStockMember" decimals="INF" unitRef="Shares"> 102860 </us-gaap:PreferredStockSharesOutstanding> | |||||||||||||||||||||
<us-gaap:PreferredStockLiquidationPreferenceValue contextRef="AsOf2022-12-31_custom_SeriesA2PreferredStockMember" decimals="0" unitRef="USD"> 1179025 </us-gaap:PreferredStockLiquidationPreferenceValue> | |||||||||||||||||||||
<us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2022-12-31_custom_SeriesA2PreferredStockMember" decimals="0" unitRef="USD"> 994019 </us-gaap:TemporaryEquityCarryingAmountAttributableToParent> | |||||||||||||||||||||
<us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2021-12-31_custom_SeriesA2PreferredStockMember" decimals="0" unitRef="USD"> 540015 </us-gaap:TemporaryEquityCarryingAmountAttributableToParent> | |||||||||||||||||||||
<us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 4023598 </us-gaap:TemporaryEquityCarryingAmountAttributableToParent> | |||||||||||||||||||||
<us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 3569594 </us-gaap:TemporaryEquityCarryingAmountAttributableToParent> | |||||||||||||||||||||
<us-gaap:DividendsPayableCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 1835089 </us-gaap:DividendsPayableCurrent> | |||||||||||||||||||||
<us-gaap:DividendsPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 1521796 </us-gaap:DividendsPayableCurrent> | |||||||||||||||||||||
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2022-12-31" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:CommonStockParOrStatedValuePerShare> | |||||||||||||||||||||
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2021-12-31" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:CommonStockParOrStatedValuePerShare> | |||||||||||||||||||||
<us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares"> 780000000 </us-gaap:CommonStockSharesAuthorized> | |||||||||||||||||||||
<us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares"> 780000000 </us-gaap:CommonStockSharesAuthorized> | |||||||||||||||||||||
<us-gaap:CommonStockSharesIssued contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares"> 6655232 </us-gaap:CommonStockSharesIssued> | |||||||||||||||||||||
<us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares"> 6655232 </us-gaap:CommonStockSharesOutstanding> | |||||||||||||||||||||
<us-gaap:CommonStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares"> 5881898 </us-gaap:CommonStockSharesIssued> | |||||||||||||||||||||
<us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares"> 5881898 </us-gaap:CommonStockSharesOutstanding> | |||||||||||||||||||||
<us-gaap:CommonStockValue contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 6655 </us-gaap:CommonStockValue> | |||||||||||||||||||||
<us-gaap:CommonStockValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 5882 </us-gaap:CommonStockValue> | |||||||||||||||||||||
<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 12378844 </us-gaap:AdditionalPaidInCapitalCommonStock> | |||||||||||||||||||||
<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 11949702 </us-gaap:AdditionalPaidInCapitalCommonStock> | |||||||||||||||||||||
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> -19812463 </us-gaap:RetainedEarningsAccumulatedDeficit> | |||||||||||||||||||||
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> -17877496 </us-gaap:RetainedEarningsAccumulatedDeficit> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> -5591875 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> -4400116 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 2353710 </us-gaap:LiabilitiesAndStockholdersEquity> | |||||||||||||||||||||
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 2932091 </us-gaap:LiabilitiesAndStockholdersEquity> | |||||||||||||||||||||
<us-gaap:ResearchAndDevelopmentExpense contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 417450 </us-gaap:ResearchAndDevelopmentExpense> | |||||||||||||||||||||
<us-gaap:ResearchAndDevelopmentExpense contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 1234215 </us-gaap:ResearchAndDevelopmentExpense> | |||||||||||||||||||||
<us-gaap:LaborAndRelatedExpense contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 343208 </us-gaap:LaborAndRelatedExpense> | |||||||||||||||||||||
<us-gaap:LaborAndRelatedExpense contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 369920 </us-gaap:LaborAndRelatedExpense> | |||||||||||||||||||||
<us-gaap:GeneralAndAdministrativeExpense contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 1253644 </us-gaap:GeneralAndAdministrativeExpense> | |||||||||||||||||||||
<us-gaap:GeneralAndAdministrativeExpense contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 1273808 </us-gaap:GeneralAndAdministrativeExpense> | |||||||||||||||||||||
<us-gaap:OperatingExpenses contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 2014302 </us-gaap:OperatingExpenses> | |||||||||||||||||||||
<us-gaap:OperatingExpenses contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 2877943 </us-gaap:OperatingExpenses> | |||||||||||||||||||||
<us-gaap:OperatingIncomeLoss contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> -2014302 </us-gaap:OperatingIncomeLoss> | |||||||||||||||||||||
<us-gaap:OperatingIncomeLoss contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> -2877943 </us-gaap:OperatingIncomeLoss> | |||||||||||||||||||||
<us-gaap:InvestmentIncomeInterest contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 1335 </us-gaap:InvestmentIncomeInterest> | |||||||||||||||||||||
<us-gaap:InvestmentIncomeInterest contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 604 </us-gaap:InvestmentIncomeInterest> | |||||||||||||||||||||
<fnam:EmployeesRetentionCredit contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 78000 </fnam:EmployeesRetentionCredit> | |||||||||||||||||||||
<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 83395 </us-gaap:GainsLossesOnExtinguishmentOfDebt> | |||||||||||||||||||||
<us-gaap:NonoperatingIncomeExpense contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 79335 </us-gaap:NonoperatingIncomeExpense> | |||||||||||||||||||||
<us-gaap:NonoperatingIncomeExpense contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 83999 </us-gaap:NonoperatingIncomeExpense> | |||||||||||||||||||||
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> -1934967 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest> | |||||||||||||||||||||
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> -2793944 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest> | |||||||||||||||||||||
<us-gaap:NetIncomeLoss contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> -1934967 </us-gaap:NetIncomeLoss> | |||||||||||||||||||||
<us-gaap:NetIncomeLoss contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> -2793944 </us-gaap:NetIncomeLoss> | |||||||||||||||||||||
<us-gaap:PreferredStockDividendsAndOtherAdjustments contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 313293 </us-gaap:PreferredStockDividendsAndOtherAdjustments> | |||||||||||||||||||||
<us-gaap:PreferredStockDividendsAndOtherAdjustments contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 285568 </us-gaap:PreferredStockDividendsAndOtherAdjustments> | |||||||||||||||||||||
<us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> -2248260 </us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic> | |||||||||||||||||||||
<us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> -3079512 </us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic> | |||||||||||||||||||||
<us-gaap:EarningsPerShareBasic contextRef="From2022-01-01to2022-12-31" decimals="INF" unitRef="USDPShares"> -0.35 </us-gaap:EarningsPerShareBasic> | |||||||||||||||||||||
<us-gaap:EarningsPerShareBasic contextRef="From2021-01-012021-12-31" decimals="INF" unitRef="USDPShares"> -0.52 </us-gaap:EarningsPerShareBasic> | |||||||||||||||||||||
<us-gaap:EarningsPerShareDiluted contextRef="From2022-01-01to2022-12-31" decimals="INF" unitRef="USDPShares"> -0.35 </us-gaap:EarningsPerShareDiluted> | |||||||||||||||||||||
<us-gaap:EarningsPerShareDiluted contextRef="From2021-01-012021-12-31" decimals="INF" unitRef="USDPShares"> -0.52 </us-gaap:EarningsPerShareDiluted> | |||||||||||||||||||||
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2022-01-01to2022-12-31" decimals="INF" unitRef="Shares"> 6458739 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic> | |||||||||||||||||||||
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2021-01-012021-12-31" decimals="INF" unitRef="Shares"> 5881898 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic> | |||||||||||||||||||||
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2022-01-01to2022-12-31" decimals="INF" unitRef="Shares"> 6458739 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding> | |||||||||||||||||||||
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2021-01-012021-12-31" decimals="INF" unitRef="Shares"> 5881898 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding> | |||||||||||||||||||||
<us-gaap:SharesOutstanding contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 5881898 </us-gaap:SharesOutstanding> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 5882 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_custom_PreferredDividendMember" decimals="0" unitRef="USD"> 1521796 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 11949702 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -17877496 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> -4400116 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 733333 </us-gaap:StockIssuedDuringPeriodSharesNewIssues> | |||||||||||||||||||||
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 733 </us-gaap:StockIssuedDuringPeriodValueNewIssues> | |||||||||||||||||||||
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 549267 </us-gaap:StockIssuedDuringPeriodValueNewIssues> | |||||||||||||||||||||
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 550000 </us-gaap:StockIssuedDuringPeriodValueNewIssues> | |||||||||||||||||||||
<fnam:StockIssuedDuringPeriodSharesStockOptionExercised contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 40001 </fnam:StockIssuedDuringPeriodSharesStockOptionExercised> | |||||||||||||||||||||
<fnam:StockIssuedDuringPeriodValueStockOptionExercised contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 40 </fnam:StockIssuedDuringPeriodValueStockOptionExercised> | |||||||||||||||||||||
<fnam:StockIssuedDuringPeriodValueStockOptionExercised contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> -40 </fnam:StockIssuedDuringPeriodValueStockOptionExercised> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 193208 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 193208 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings contextRef="From2022-01-012022-12-31_custom_PreferredDividendMember" decimals="0" unitRef="USD"> 313293 </us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> -313293 </us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings> | |||||||||||||||||||||
<us-gaap:ProfitLoss contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -1934967 </us-gaap:ProfitLoss> | |||||||||||||||||||||
<us-gaap:ProfitLoss contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> -1934967 </us-gaap:ProfitLoss> | |||||||||||||||||||||
<us-gaap:SharesOutstanding contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 6655232 </us-gaap:SharesOutstanding> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 6655 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2022-12-31_custom_PreferredDividendMember" decimals="0" unitRef="USD"> 1835089 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 12378844 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -19812463 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> -5591875 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:SharesOutstanding contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 5881898 </us-gaap:SharesOutstanding> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 5882 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_custom_PreferredDividendMember" decimals="0" unitRef="USD"> 1236228 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 12015552 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -15083552 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD"> -1825890 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 219718 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 219718 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings contextRef="From2021-01-012021-12-31_custom_PreferredDividendMember" decimals="0" unitRef="USD"> 285568 </us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings> | |||||||||||||||||||||
<us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> -285568 </us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings> | |||||||||||||||||||||
<us-gaap:ProfitLoss contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -2793944 </us-gaap:ProfitLoss> | |||||||||||||||||||||
<us-gaap:ProfitLoss contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> -2793944 </us-gaap:ProfitLoss> | |||||||||||||||||||||
<us-gaap:SharesOutstanding contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 5881898 </us-gaap:SharesOutstanding> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 5882 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_custom_PreferredDividendMember" decimals="0" unitRef="USD"> 1521796 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 11949702 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -17877496 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> -4400116 </us-gaap:StockholdersEquity> | |||||||||||||||||||||
<us-gaap:NetIncomeLoss contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> -1934967 </us-gaap:NetIncomeLoss> | |||||||||||||||||||||
<us-gaap:NetIncomeLoss contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> -2793944 </us-gaap:NetIncomeLoss> | |||||||||||||||||||||
<us-gaap:DepreciationDepletionAndAmortization contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 1021493 </us-gaap:DepreciationDepletionAndAmortization> | |||||||||||||||||||||
<us-gaap:DepreciationDepletionAndAmortization contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 1038816 </us-gaap:DepreciationDepletionAndAmortization> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensation contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 193208 </us-gaap:ShareBasedCompensation> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensation contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 219718 </us-gaap:ShareBasedCompensation> | |||||||||||||||||||||
<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 83395 </us-gaap:GainsLossesOnExtinguishmentOfDebt> | |||||||||||||||||||||
<fnam:EmployeesRetentionCredit contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 78000 </fnam:EmployeesRetentionCredit> | |||||||||||||||||||||
<us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 2055 </us-gaap:IncreaseDecreaseInPrepaidExpense> | |||||||||||||||||||||
<us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> -19965 </us-gaap:IncreaseDecreaseInPrepaidExpense> | |||||||||||||||||||||
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 159374 </us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities> | |||||||||||||||||||||
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 15702 </us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities> | |||||||||||||||||||||
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> -640947 </us-gaap:NetCashProvidedByUsedInOperatingActivities> | |||||||||||||||||||||
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> -1583138 </us-gaap:NetCashProvidedByUsedInOperatingActivities> | |||||||||||||||||||||
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 550000 </us-gaap:ProceedsFromIssuanceOfCommonStock> | |||||||||||||||||||||
<us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 454004 </us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock> | |||||||||||||||||||||
<us-gaap:ProceedsFromNotesPayable contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 1447916 </us-gaap:ProceedsFromNotesPayable> | |||||||||||||||||||||
<fnam:ProceedsFromEidlAndPppLoans contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 133395 </fnam:ProceedsFromEidlAndPppLoans> | |||||||||||||||||||||
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 1004004 </us-gaap:NetCashProvidedByUsedInFinancingActivities> | |||||||||||||||||||||
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 1581311 </us-gaap:NetCashProvidedByUsedInFinancingActivities> | |||||||||||||||||||||
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 363057 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect> | |||||||||||||||||||||
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> -1827 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect> | |||||||||||||||||||||
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 214009 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents> | |||||||||||||||||||||
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2020-12-31" decimals="0" unitRef="USD"> 215836 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents> | |||||||||||||||||||||
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 577066 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents> | |||||||||||||||||||||
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 214009 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents> | |||||||||||||||||||||
<fnam:PreferredStockDividendAccretion contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 313293 </fnam:PreferredStockDividendAccretion> | |||||||||||||||||||||
<fnam:PreferredStockDividendAccretion contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 285568 </fnam:PreferredStockDividendAccretion> | |||||||||||||||||||||
<us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_809_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zCPBeHPZyoLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline">Note 1: <span id="xdx_82E_zXqKh3whWSab">Business Activity</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">Evolutionary Genomics, Inc. (the “Company,” “We,” or “Our”) has developed a technology platform, the Adapted Traits Platform (“ATP”), to identify commercially valuable genes that control important traits in animals and plants. We are using the ATP to identify genes to improve crop plant traits such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. Our platform identifies key genes that have changed successfully to impart new or improved traits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">In the past, the Company performed research on behalf of governmental organizations, non-profit foundations and commercial entities and received revenue from grants and commercial research contracts. We have not received any revenue from these grant arrangements since early 2020. The Company now focuses on research projects that may lead to long-term licensing arrangements with agricultural seed companies and crop producers as with our soybean and banana projects. These projects take several years to develop, and successful commercialization may take many years to produce license royalty payments. Our banana project, in cooperation with Dole Food Company is an example that has resulted in notes payable funding for the development phase of our banana genes and may result in a long-term royalty bearing license once the development phase is complete.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">During 2014, the Company purchased 75.16% of the outstanding stock of Fona, Inc., (“Fona”) a public shell company. Since Fona was a public shell company which did not constitute a business and the purchase was done in contemplation of a reverse merger, the Company accounted for the payment as a distribution to Fona shareholders. The Company also entered into an Agreement and Plan of Merger (the “Merger”), which was consummated on October 19, 2015. As a result of the Merger, Evolutionary Genomics, Inc. became a wholly owned subsidiary of Fona. For accounting purposes, the merger was treated as a reverse acquisition with Evolutionary Genomics, Inc. as the acquirer and Fona as the acquired party. Subsequent to the Merger, Fona was renamed Evolutionary Genomics, Inc. and our subsidiary was renamed from Evolutionary Genomics, Inc. to EG Crop Science, Inc.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock> | |||||||||||||||||||||
<us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_801_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_zeYet9QwXJrj" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Note 2: <span id="xdx_82A_zNyRSBnYJAG8">Summary of Significant Accounting Policies</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b> </b></span></p> <p id="xdx_847_eus-gaap--ConsolidationPolicyTextBlock_zvwCD3bnKw3b" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zUE7DX2auyJd">Principals of Consolidation</span></span>: These consolidated financial statements include the accounts of Evolutionary Genomics, Inc. and its wholly owned subsidiaries. All material intercompany transactions and balances have been eliminated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--UseOfEstimates_zZqgcZmAkPqa" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zCIcreUE5Gk3">Use of Estimates</span></span>: The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">These consolidated financial statements have been prepared on the basis of going concern. Management’s plans to address the Company’s liquidity are discussed further in Note 13.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zAkZkkb91sle" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zzO9l99jqDhc">Cash</span></span>: The Company considers all highly liquid investments purchased with an original or remaining maturity of three months or less when purchased to be cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--EmployeeRetentionCreditPolicyTextBlock_zvtZ3dxAwwJg" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zPh07bJCoUC">Employee Retention Credit</span></span>: During the year ended December 31, 2022, the Company filed forms 941-X for the quarters ending December 31, 2020, March 31, 2021, June 30, 2021 and September 30, 2021 and expects to receive refunds totaling $<span id="xdx_905_eus-gaap--IncomeTaxReceivable_iI_c20221231_za3MjJwtVFBe" title="Employee retention credit">78,000</span>. Subsequent to December 31, 2022, the Company received a $<span id="xdx_909_eus-gaap--ProceedsFromIncomeTaxRefunds_c20230101__20230309__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zwh3xg1U8a33" title="Employee retention credit received">21,000</span> refund for the quarter ended September 30, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zHWibjdo7xJ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zXKnTXxtkv5a">Property and Equipment</span></span>: Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is provided for by the straight-line method over three- to seven-year estimated useful lives of software, furniture and fixtures and equipment. Maintenance and repairs are expensed as incurred; major renewals and betterments that extend the useful lives of property and equipment are capitalized. When property and equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zM99AXH6O88h" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zwmNUXIyv6bd">Long-Lived Assets</span></span>: The long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that facts and circumstances indicate that the cost of any long-lived assets may be impaired, an evaluation of recoverability is performed. An impairment is considered to exist if the total estimated undiscounted cash flows are less than the carrying amount of the asset. An impairment loss is measured and recorded to the extent that the carrying amount of the asset exceeds its estimated fair value. No asset impairment was recorded during the years ended December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24pc"><span style="font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zl4NDTcmkYTb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_ztcybmXYJ2f4">Intangible Assets</span></span>: Intangible assets include acquired research in progress and patents on the Company’s core technology for gene identification. Previously acquired patents were capitalized and are amortized over their expected useful life of 20 years using the straight-line method. Acquired research in progress was placed into service on August 19, 2020 in conjunction with the Development and Commercialization Agreement and is being amortized over four years consistent with the term of the Dole agreement using the straight-line method. Costs incurred to renew intangible assets and to file new patent applications are expensed in the period incurred, while costs incurred to extend the lives of patents are capitalized and amortized over the remaining useful life of the asset. Intangible assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that facts and circumstances indicate that the cost of any intangible assets may be impaired, an evaluation of recoverability is performed. An impairment is considered to exist if the total estimated undiscounted cash flows are less than the carrying amount of the asset. No impairment was recorded during the years ended December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zLUTPhUQTj92" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zICqC7h1mfQa">Income Taxes</span></span>: Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. Management regularly assesses the likelihood that deferred tax assets will be recovered from future taxable income, and to the extent management believes that it is more likely than not that a deferred tax asset will not be realized, a valuation allowance is established. When a valuation allowance is established, increased or decreased, an income tax charge or benefit is included in the consolidated financial statements and net deferred tax assets are adjusted accordingly. As of December 31, 2022 and 2021, a full valuation allowance has been established on the net deferred tax asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">Under the Income Tax topic of the ASC, in order to recognize an uncertain tax benefit, the taxpayer must be more likely than not of sustaining the position, and the measurement of the benefit is calculated as the largest amount that is more than 50% likely to be realized upon resolution of the benefit. The Company has no accruals for uncertain tax benefits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zP9wED4crbh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zfabAZhxQKOj">Stock-Based Compensation</span></span>: The Company accounts for stock option awards in accordance with ASC 718. The estimated grant-date fair value of stock-based awards is expensed over the requisite service period, which is typically equivalent to the vesting term of the award.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">The Company’s accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services received follows the provisions of ASC Topic 718. Accordingly, the measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached or (ii) the date at which the consultant or vendor’s performance is complete.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ResearchAndDevelopmentExpensePolicy_zOWsoUyD1fWf" style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span id="a_Aci_Pg39"/><span style="text-decoration: underline"><span id="xdx_865_z9Sh8BuYr5Uc">Research and Development</span></span>: Research and development costs are expensed as incurred. In instances where we enter into agreements with third parties for research and development activities, we may prepay for services at the initiation of the contract. We record the prepayment as a prepaid asset and amortize the asset into research and development expense over the period of time the contracted research and development services are performed.</span></p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zdySxykMGUb6" style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zjMO97kixeQ1">Net Loss Per Common Share</span></span>: Basic net (loss) income per common share excludes any dilutive effects of equity instruments. We compute basic net (loss) income per common share using the weighted average number of common shares outstanding during the period. We compute diluted net (loss) income per common share using the weighted average number of common shares and common stock equivalents outstanding during the period. For the year ended December 31, 2022, common stock equivalents including <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zHwxCGJkAMZc" title="Antidilutive shares">766,400</span> shares of convertible preferred stock and options for <span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zPYFe9PDwPs9" title="Antidilutive shares">1,028,333</span> shares of common stock and for the year ended December 31, 2021, common stock equivalents including <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_pdd" title="Antidilutive shares">679,923</span> shares of convertible preferred stock and options for <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--OptionMember_pdd" title="Antidilutive shares">1,081,667</span> shares of common stock were excluded because their effect was anti-dilutive.</span></p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock> | |||||||||||||||||||||
<us-gaap:ConsolidationPolicyTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_847_eus-gaap--ConsolidationPolicyTextBlock_zvwCD3bnKw3b" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zUE7DX2auyJd">Principals of Consolidation</span></span>: These consolidated financial statements include the accounts of Evolutionary Genomics, Inc. and its wholly owned subsidiaries. All material intercompany transactions and balances have been eliminated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:ConsolidationPolicyTextBlock> | |||||||||||||||||||||
<us-gaap:UseOfEstimates contextRef="From2022-01-01to2022-12-31"> <p id="xdx_843_eus-gaap--UseOfEstimates_zZqgcZmAkPqa" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zCIcreUE5Gk3">Use of Estimates</span></span>: The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">These consolidated financial statements have been prepared on the basis of going concern. Management’s plans to address the Company’s liquidity are discussed further in Note 13.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:UseOfEstimates> | |||||||||||||||||||||
<us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zAkZkkb91sle" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zzO9l99jqDhc">Cash</span></span>: The Company considers all highly liquid investments purchased with an original or remaining maturity of three months or less when purchased to be cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:CashAndCashEquivalentsPolicyTextBlock> | |||||||||||||||||||||
<fnam:EmployeeRetentionCreditPolicyTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_845_ecustom--EmployeeRetentionCreditPolicyTextBlock_zvtZ3dxAwwJg" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zPh07bJCoUC">Employee Retention Credit</span></span>: During the year ended December 31, 2022, the Company filed forms 941-X for the quarters ending December 31, 2020, March 31, 2021, June 30, 2021 and September 30, 2021 and expects to receive refunds totaling $<span id="xdx_905_eus-gaap--IncomeTaxReceivable_iI_c20221231_za3MjJwtVFBe" title="Employee retention credit">78,000</span>. Subsequent to December 31, 2022, the Company received a $<span id="xdx_909_eus-gaap--ProceedsFromIncomeTaxRefunds_c20230101__20230309__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zwh3xg1U8a33" title="Employee retention credit received">21,000</span> refund for the quarter ended September 30, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </fnam:EmployeeRetentionCreditPolicyTextBlock> | |||||||||||||||||||||
<us-gaap:IncomeTaxReceivable contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 78000 </us-gaap:IncomeTaxReceivable> | |||||||||||||||||||||
<us-gaap:ProceedsFromIncomeTaxRefunds contextRef="From2023-01-012023-03-09_us-gaap_SubsequentEventMember" decimals="0" unitRef="USD"> 21000 </us-gaap:ProceedsFromIncomeTaxRefunds> | |||||||||||||||||||||
<us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_848_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zHWibjdo7xJ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zXKnTXxtkv5a">Property and Equipment</span></span>: Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is provided for by the straight-line method over three- to seven-year estimated useful lives of software, furniture and fixtures and equipment. Maintenance and repairs are expensed as incurred; major renewals and betterments that extend the useful lives of property and equipment are capitalized. When property and equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:PropertyPlantAndEquipmentPolicyTextBlock> | |||||||||||||||||||||
<us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zM99AXH6O88h" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zwmNUXIyv6bd">Long-Lived Assets</span></span>: The long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that facts and circumstances indicate that the cost of any long-lived assets may be impaired, an evaluation of recoverability is performed. An impairment is considered to exist if the total estimated undiscounted cash flows are less than the carrying amount of the asset. An impairment loss is measured and recorded to the extent that the carrying amount of the asset exceeds its estimated fair value. No asset impairment was recorded during the years ended December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24pc"><span style="font-size: 10pt"> </span></p> </us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock> | |||||||||||||||||||||
<us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zl4NDTcmkYTb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_ztcybmXYJ2f4">Intangible Assets</span></span>: Intangible assets include acquired research in progress and patents on the Company’s core technology for gene identification. Previously acquired patents were capitalized and are amortized over their expected useful life of 20 years using the straight-line method. Acquired research in progress was placed into service on August 19, 2020 in conjunction with the Development and Commercialization Agreement and is being amortized over four years consistent with the term of the Dole agreement using the straight-line method. Costs incurred to renew intangible assets and to file new patent applications are expensed in the period incurred, while costs incurred to extend the lives of patents are capitalized and amortized over the remaining useful life of the asset. Intangible assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that facts and circumstances indicate that the cost of any intangible assets may be impaired, an evaluation of recoverability is performed. An impairment is considered to exist if the total estimated undiscounted cash flows are less than the carrying amount of the asset. No impairment was recorded during the years ended December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock> | |||||||||||||||||||||
<us-gaap:IncomeTaxPolicyTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zLUTPhUQTj92" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zICqC7h1mfQa">Income Taxes</span></span>: Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. Management regularly assesses the likelihood that deferred tax assets will be recovered from future taxable income, and to the extent management believes that it is more likely than not that a deferred tax asset will not be realized, a valuation allowance is established. When a valuation allowance is established, increased or decreased, an income tax charge or benefit is included in the consolidated financial statements and net deferred tax assets are adjusted accordingly. As of December 31, 2022 and 2021, a full valuation allowance has been established on the net deferred tax asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">Under the Income Tax topic of the ASC, in order to recognize an uncertain tax benefit, the taxpayer must be more likely than not of sustaining the position, and the measurement of the benefit is calculated as the largest amount that is more than 50% likely to be realized upon resolution of the benefit. The Company has no accruals for uncertain tax benefits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:IncomeTaxPolicyTextBlock> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2022-01-01to2022-12-31"> <p id="xdx_848_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zP9wED4crbh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zfabAZhxQKOj">Stock-Based Compensation</span></span>: The Company accounts for stock option awards in accordance with ASC 718. The estimated grant-date fair value of stock-based awards is expensed over the requisite service period, which is typically equivalent to the vesting term of the award.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">The Company’s accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services received follows the provisions of ASC Topic 718. Accordingly, the measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached or (ii) the date at which the consultant or vendor’s performance is complete.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy> | |||||||||||||||||||||
<us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2022-01-01to2022-12-31"> <p id="xdx_840_eus-gaap--ResearchAndDevelopmentExpensePolicy_zOWsoUyD1fWf" style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span id="a_Aci_Pg39"/><span style="text-decoration: underline"><span id="xdx_865_z9Sh8BuYr5Uc">Research and Development</span></span>: Research and development costs are expensed as incurred. In instances where we enter into agreements with third parties for research and development activities, we may prepay for services at the initiation of the contract. We record the prepayment as a prepaid asset and amortize the asset into research and development expense over the period of time the contracted research and development services are performed.</span></p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:ResearchAndDevelopmentExpensePolicy> | |||||||||||||||||||||
<us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zdySxykMGUb6" style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zjMO97kixeQ1">Net Loss Per Common Share</span></span>: Basic net (loss) income per common share excludes any dilutive effects of equity instruments. We compute basic net (loss) income per common share using the weighted average number of common shares outstanding during the period. We compute diluted net (loss) income per common share using the weighted average number of common shares and common stock equivalents outstanding during the period. For the year ended December 31, 2022, common stock equivalents including <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zHwxCGJkAMZc" title="Antidilutive shares">766,400</span> shares of convertible preferred stock and options for <span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zPYFe9PDwPs9" title="Antidilutive shares">1,028,333</span> shares of common stock and for the year ended December 31, 2021, common stock equivalents including <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_pdd" title="Antidilutive shares">679,923</span> shares of convertible preferred stock and options for <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--OptionMember_pdd" title="Antidilutive shares">1,081,667</span> shares of common stock were excluded because their effect was anti-dilutive.</span></p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:EarningsPerSharePolicyTextBlock> | |||||||||||||||||||||
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2022-01-012022-12-31_us-gaap_ConvertibleDebtSecuritiesMember" decimals="INF" unitRef="Shares"> 766400 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> | |||||||||||||||||||||
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2022-01-012022-12-31_us-gaap_OptionMember" decimals="INF" unitRef="Shares"> 1028333 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> | |||||||||||||||||||||
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2021-01-012021-12-31_us-gaap_ConvertibleDebtSecuritiesMember" decimals="INF" unitRef="Shares"> 679923 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> | |||||||||||||||||||||
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2021-01-012021-12-31_us-gaap_OptionMember" decimals="INF" unitRef="Shares"> 1081667 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> | |||||||||||||||||||||
<us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_807_eus-gaap--NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_zMBJfc2iF4w6" style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Note 3: <span id="xdx_822_zL44tCKX487g">New Accounting Standards</span></span></b></span></p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b> </b></span></p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Recently Issued Accounting Standards</span></b></span></p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments,” which requires entities to estimate all expected credit losses for certain types of financial instruments, including trade receivables, held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. The updated guidance also expands the disclosure requirements to enable users of financial statements to understand the entity’s assumptions, models and methods for estimating expected credit losses over the entire contractual term of the instrument from the date of initial recognition of that instrument. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within that reporting period and is not expected to have an impact on the Company’s consolidated financial statements.<span id="a_Aci_Pg40"/></span></p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock> | |||||||||||||||||||||
<us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_809_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zvMRo6SB0tTg" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Note 4: <span id="xdx_823_zOxW4NNgpbF4">Property and Equipment</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">Property and equipment is comprised of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zqN6qAEIv4Qg" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment (Details)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B1_zkeI2wjP40Hk" style="display: none">Schedule of Property and Equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 74%">Equipment</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Property and equipment, gross">432,499</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Property and equipment, gross">432,499</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif">Software</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">63,179</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">63,179</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Furniture and fixtures</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">7,987</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">7,987</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font-size: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20221231_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">503,665</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">503,665</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accumulated depreciation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_zVb2DpKmtWZj" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation">(499,709</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_z23fRlqQ8Ln4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation">(484,967</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net">3,956</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net">18,698</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">Depreciation expense for the years ended December 31, 2022 and 2021 was $<span id="xdx_90F_eus-gaap--Depreciation_c20220101__20221231_pp0p0" title="Depreciation expense">14,742</span> and $<span id="xdx_906_eus-gaap--Depreciation_pp0p0_c20210101__20211231_zBufnTIP3vI2" title="Depreciation expense">32,065</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock> | |||||||||||||||||||||
<us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2022-01-01to2022-12-31"> <table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zqN6qAEIv4Qg" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment (Details)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B1_zkeI2wjP40Hk" style="display: none">Schedule of Property and Equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 74%">Equipment</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Property and equipment, gross">432,499</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Property and equipment, gross">432,499</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif">Software</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">63,179</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">63,179</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Furniture and fixtures</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">7,987</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">7,987</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font-size: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20221231_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">503,665</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">503,665</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accumulated depreciation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_zVb2DpKmtWZj" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation">(499,709</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_z23fRlqQ8Ln4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation">(484,967</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net">3,956</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net">18,698</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </us-gaap:PropertyPlantAndEquipmentTextBlock> | |||||||||||||||||||||
<us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2022-12-31_us-gaap_EquipmentMember" decimals="0" unitRef="USD"> 432499 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
<us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-12-31_us-gaap_EquipmentMember" decimals="0" unitRef="USD"> 432499 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
<us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2022-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" decimals="0" unitRef="USD"> 63179 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
<us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" decimals="0" unitRef="USD"> 63179 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
<us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2022-12-31_us-gaap_FurnitureAndFixturesMember" decimals="0" unitRef="USD"> 7987 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
<us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember" decimals="0" unitRef="USD"> 7987 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
<us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 503665 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
<us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 503665 </us-gaap:PropertyPlantAndEquipmentGross> | |||||||||||||||||||||
<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 499709 </us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment> | |||||||||||||||||||||
<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 484967 </us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment> | |||||||||||||||||||||
<us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 3956 </us-gaap:PropertyPlantAndEquipmentNet> | |||||||||||||||||||||
<us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 18698 </us-gaap:PropertyPlantAndEquipmentNet> | |||||||||||||||||||||
<us-gaap:Depreciation contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 14742 </us-gaap:Depreciation> | |||||||||||||||||||||
<us-gaap:Depreciation contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 32065 </us-gaap:Depreciation> | |||||||||||||||||||||
<us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_80E_eus-gaap--IntangibleAssetsDisclosureTextBlock_zGUGO6Hf5vT" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Note 5: <span id="xdx_82D_zr5ICovQZCk">Intangible Assets</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">Intangible assets are comprised of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zGgS5CTSJ5Ch" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible Assets (Details)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BB_zVqjJrTCbLF2" style="display: none">Schedule of Intangible Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 74%; text-align: left">Acquired research in progress - definite lived</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--InProcessResearchAndDevelopmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Intangible assets, gross">4,016,596</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--InProcessResearchAndDevelopmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Intangible assets, gross">4,016,596</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif">Patents</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, gross">52,045</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, gross">52,045</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accumulated amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, accumulated amortization">(2,417,800</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, accumulated amortization">(1,411,049</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net">1,650,841</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net">2,657,592</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zVKtlgXEH6uc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The Company expects to recognize amortization expense related to its acquired research in progress and patents according to the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zFMeFAHJRkEl" style="margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - Intangible Assets (Details 1)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span id="xdx_8B7_z1xL4w5EBQcl" style="display: none">Schedule of Intangible Assets Amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">Year Ending</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Amortization</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: left"><span style="font-size: 10pt">December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20221231_zIQPeTQNvuWk" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">1,006,751</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-size: 10pt">December 31, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20221231_ziVpGMNmiHvb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="December 31, 2024">638,105</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-size: 10pt">December 31, 2025</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20221231_zyWYgSvGFeVd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="December 31, 2025">2,602</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-size: 10pt">December 31, 2026</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20221231_zgZofLBVW59i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="December 31, 2026">2,602</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-size: 10pt">December 31, 2027</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20221231_ztc3xU6LnyYd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="December 31, 2027">781</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-size: 10pt"> Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231_z82zoJx2DRN8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total">1,650,841</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zSKLfb1qkJc1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><span id="a_Hlk46476717"/>Amortization expense for the acquired research in progress and patents during the years ended December 31, 2022 and 2021 was $<span id="xdx_901_eus-gaap--AdjustmentForAmortization_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="Amortization"><span id="xdx_903_eus-gaap--AdjustmentForAmortization_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="Amortization">1,006,751</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">In its merger completed on October 19, 2015, the Company acquired research in progress. The value of the acquired research in progress was based upon several factors including, evaluation of other intangible assets, the purchase price, estimated future cash flows, and the amounts expended on the research to date. The research in progress was the identification and validation of genes to provide pest and disease resistance to plants performed by EG I. With the banana development project contract in place, the Company placed this asset in service on August 19, 2020. Additional costs to complete the soybean research are expected to be approximately $<span id="xdx_903_ecustom--AdditionalExpectedCostsToCompleteResearch_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--InProcessResearchAndDevelopmentMember_pp0p0" title="Additional expected costs to complete research">33,000</span>, which will be expensed as incurred. The timing and cost of additional research may vary from these estimates as the success of the research is subject to many factors outside of the Company’s control.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b> </b></span></p> </us-gaap:IntangibleAssetsDisclosureTextBlock> | |||||||||||||||||||||
<us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2022-01-01to2022-12-31"> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zGgS5CTSJ5Ch" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible Assets (Details)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BB_zVqjJrTCbLF2" style="display: none">Schedule of Intangible Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 74%; text-align: left">Acquired research in progress - definite lived</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--InProcessResearchAndDevelopmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Intangible assets, gross">4,016,596</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--InProcessResearchAndDevelopmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Intangible assets, gross">4,016,596</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif">Patents</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, gross">52,045</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, gross">52,045</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accumulated amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, accumulated amortization">(2,417,800</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, accumulated amortization">(1,411,049</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net">1,650,841</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net">2,657,592</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock> | |||||||||||||||||||||
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2022-12-31_us-gaap_InProcessResearchAndDevelopmentMember" decimals="0" unitRef="USD"> 4016596 </us-gaap:FiniteLivedIntangibleAssetsGross> | |||||||||||||||||||||
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2021-12-31_us-gaap_InProcessResearchAndDevelopmentMember" decimals="0" unitRef="USD"> 4016596 </us-gaap:FiniteLivedIntangibleAssetsGross> | |||||||||||||||||||||
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2022-12-31_us-gaap_PatentsMember" decimals="0" unitRef="USD"> 52045 </us-gaap:FiniteLivedIntangibleAssetsGross> | |||||||||||||||||||||
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2021-12-31_us-gaap_PatentsMember" decimals="0" unitRef="USD"> 52045 </us-gaap:FiniteLivedIntangibleAssetsGross> | |||||||||||||||||||||
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> -2417800 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization> | |||||||||||||||||||||
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> -1411049 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization> | |||||||||||||||||||||
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 1650841 </us-gaap:FiniteLivedIntangibleAssetsNet> | |||||||||||||||||||||
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 2657592 </us-gaap:FiniteLivedIntangibleAssetsNet> | |||||||||||||||||||||
<us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="From2022-01-01to2022-12-31"> <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zFMeFAHJRkEl" style="margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - Intangible Assets (Details 1)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span id="xdx_8B7_z1xL4w5EBQcl" style="display: none">Schedule of Intangible Assets Amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">Year Ending</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Amortization</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: left"><span style="font-size: 10pt">December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20221231_zIQPeTQNvuWk" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">1,006,751</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-size: 10pt">December 31, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20221231_ziVpGMNmiHvb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="December 31, 2024">638,105</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-size: 10pt">December 31, 2025</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20221231_zyWYgSvGFeVd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="December 31, 2025">2,602</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-size: 10pt">December 31, 2026</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20221231_zgZofLBVW59i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="December 31, 2026">2,602</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-size: 10pt">December 31, 2027</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20221231_ztc3xU6LnyYd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="December 31, 2027">781</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-size: 10pt"> Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231_z82zoJx2DRN8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total">1,650,841</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock> | |||||||||||||||||||||
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 1006751 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths> | |||||||||||||||||||||
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 638105 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo> | |||||||||||||||||||||
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 2602 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree> | |||||||||||||||||||||
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 2602 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour> | |||||||||||||||||||||
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 781 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive> | |||||||||||||||||||||
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 1650841 </us-gaap:FiniteLivedIntangibleAssetsNet> | |||||||||||||||||||||
<us-gaap:AdjustmentForAmortization contextRef="From2022-01-012022-12-31_us-gaap_PatentsMember" decimals="0" unitRef="USD"> 1006751 </us-gaap:AdjustmentForAmortization> | |||||||||||||||||||||
<us-gaap:AdjustmentForAmortization contextRef="From2021-01-012021-12-31_us-gaap_PatentsMember" decimals="0" unitRef="USD"> 1006751 </us-gaap:AdjustmentForAmortization> | |||||||||||||||||||||
<fnam:AdditionalExpectedCostsToCompleteResearch contextRef="AsOf2022-12-31_us-gaap_InProcessResearchAndDevelopmentMember" decimals="0" unitRef="USD"> 33000 </fnam:AdditionalExpectedCostsToCompleteResearch> | |||||||||||||||||||||
<us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_803_eus-gaap--IncomeTaxDisclosureTextBlock_zFEl5BfESDH3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span id="a_Aci_Pg42"/><b><span style="text-decoration: underline">Note 6: <span id="xdx_820_zOsZTUZGJ1T2">Income Taxes</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">For the years ended December 31, 2022 and 2021, the Company did not recognize any current or deferred income tax benefit or expense. For the years ended December 31, 2022 and 2021, the reconciliation between the income tax benefit computed by applying the statutory U.S. federal income tax rate of <span id="xdx_907_ecustom--FutureFederalStatutoryTaxRates_iI_dp_c20221231_z9ScXU7MRSRk" title="Future federal statutory tax rate"><span id="xdx_906_ecustom--FutureFederalStatutoryTaxRates_iI_dp_c20211231_zuLqo8MgRAQi" title="Future federal statutory tax rate">21.0</span></span>% to the pre-tax loss before income taxes, and total income tax benefit (expense) recognized in the financial statements is as follows</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zTPTqxyCEDd8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left; padding-left: 2.75pt"><span id="xdx_8BD_zr8ollxNiDUc" style="display: none">Schedule of income tax rate reconciliation</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20220101__20221231_zG8hatPzxrL" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td> <td id="xdx_496_20210101__20211231_zHk46icvK7Dc" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: center"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxReconciliationDispositionOfBusiness_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="width: 74%; text-align: left; padding-left: 2.75pt">Income tax benefit at statutory U.S. federal rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">406,343</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 10%; text-align: right">586,728</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ForeignIncomeTaxExpenseBenefitContinuingOperations_i_pp0p0" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left; padding-left: 2.75pt">Income tax benefit attributable to U.S. states</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">67,259</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right">99,325</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--ResearchAndDevelopmentCredits_zBOXKVQ07Gm6" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left; padding-left: 2.75pt">Research and development credits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(66,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right">137,728</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--NontaxableForgivenessOfPppAndEidlLoans_i_pp0p0" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left; padding-left: 2.75pt">Non-taxable forgiveness of PPP and EIDL loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0539">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right">20,478</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--NondeductibleExpenses_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left; padding-left: 2.75pt">Non-deductible expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(299</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(300</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--StockOptionPlanExpense_i_pp0p0" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left; padding-left: 2.75pt">Stock- based compensation related to incentive stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(47,290</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(53,952</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--OtherComprehensiveIncomeLossNetOfTax_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-left: 2.75pt">Other changes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(7,439</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(15,182</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_i_pp0p0" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 2.75pt">Change in valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(352,574</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(774,825</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredIncomeTaxesAndTaxCredits_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.7pt"> Total income tax expense (benefit)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0554">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0555">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zA0bXFqhFG1l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">As of December 31, 2022 and 2021, the components of deferred income tax assets and liabilities were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zUPnLXvHtc5i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B4_z3qQ94rrFGE2" style="display: none">Schedule of deferred tax assets and liabilities</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20221231_zGv5IITw0A7c" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td> <td id="xdx_497_20211231_ze3yjKrD5R67" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: center"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left">Deferred income tax assets:</td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td> <td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0" style="vertical-align: bottom"> <td style="width: 74%; text-align: left"> Net operating loss carryforwards</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">2,928,442</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 10%; text-align: right">2,876,543</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left"> Research and development credits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">449,981</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right">515,982</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_i01I_pp0p0_zAWvXnDCy0D9" style="vertical-align: bottom"> <td style="text-align: left"> Accrued Compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0569">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--LongtermCapitalLossCarryforward_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left"> Long-term capital loss carryforward</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">94,445</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right">94,728</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di_z8bJBz1LDnHh" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt"> Valuation allowance for deferred income tax assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,187,682</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(2,835,108</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left; padding-bottom: 1pt"> Net deferred income tax assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">308,853</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">652,145</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left">Deferred income tax liabilities:</td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td> <td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_i01NI_pp0p0_di_zTE3FwEE4d1g" style="vertical-align: bottom; background-color: transparent"> <td style="width: 74%; text-align: left"> Intangible assets</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">(307,885</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 10%; text-align: right">(647,554</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentOther_i01NI_pp0p0_di_zqDteaSGXBNj" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left; padding-bottom: 1pt"> Property, equipment and other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(968</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(4,591</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--DeferredIncomeTaxLiabilities_i01NI_pp0p0_di_zJg2PVwC2oQi" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left; padding-bottom: 1pt"> Total deferred income tax liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(308,853</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(652,145</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxLiabilities_iNI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left; padding-bottom: 2.5pt">Net deferred income tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0592">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0593">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zJfUEt1qRK24" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span id="a_Aci_Pg43"/>The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to reverse.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">The Company records a valuation allowance for certain temporary differences for which it is more likely than not that a future tax benefit will be received. The Company assesses its past earnings history and trends and projections of future net income. The Company recorded a valuation allowance for the entire amount of the net deferred tax asset as of December 31, 2022 and 2021. As of December 31, 2022, the Company had a total valuation allowance of approximately $<span id="xdx_901_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_c20220101__20221231_pp0p0" title="Increase (decrease) in Valuation Allowance">3,188,000</span> for its deferred tax assets. The Company will continue to review this valuation allowance and make adjustments as appropriate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">As of December 31, 2022, the Company had net operating loss (“NOL”) carryforwards of approximately $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_c20221231_pp0p0" title="Net operating loss">11,965,000</span>, consisting of $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_c20211231_pp0p0" title="Net operating loss">5,545,000</span> that have an indefinite carryover period and $<span id="xdx_90D_ecustom--IndefiniteCarryforward_c20211231_pp0p0" title="Indefinite Carry-forward">6,420,000</span> that expire at various intervals through 2037. Use of NOL carryforwards is limited by the provisions of Section 382 of the Internal Revenue Code. At this point, the Company has not performed an analysis to determine whether an ownership change (as defined under Section 382) occurred during this year or preceding years. A determination of the potential impact these provisions might have on the utilization of net operating losses will be made when the net operating loss is projected to be utilized. As of December 31, 2022, the Company also has a capital loss carryforward of approximately $<span id="xdx_903_ecustom--CapitalLossCredits_c20221231_pp0p0" title="Capital Loss credits">386,000</span> that expires in 2025, and a research and development credit carryforward of approximately $<span id="xdx_909_eus-gaap--TaxCreditCarryforwardAmount_c20221231_pp0p0" title="R&D credits">450,000</span> that will expire at various intervals from 2030 through 2040.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt">The calculation of the Company’s tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations. ASC 740 states that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, on the basis of the technical merits. At this time, the Company does not have any uncertain tax positions to assess.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b> </b></span></p> </us-gaap:IncomeTaxDisclosureTextBlock> | |||||||||||||||||||||
<fnam:FutureFederalStatutoryTaxRates contextRef="AsOf2022-12-31" decimals="INF" unitRef="Pure"> 0.210 </fnam:FutureFederalStatutoryTaxRates> | |||||||||||||||||||||
<fnam:FutureFederalStatutoryTaxRates contextRef="AsOf2021-12-31" decimals="INF" unitRef="Pure"> 0.210 </fnam:FutureFederalStatutoryTaxRates> | |||||||||||||||||||||
<us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2022-01-01to2022-12-31"> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zTPTqxyCEDd8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left; padding-left: 2.75pt"><span id="xdx_8BD_zr8ollxNiDUc" style="display: none">Schedule of income tax rate reconciliation</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20220101__20221231_zG8hatPzxrL" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td> <td id="xdx_496_20210101__20211231_zHk46icvK7Dc" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: center"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxReconciliationDispositionOfBusiness_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="width: 74%; text-align: left; padding-left: 2.75pt">Income tax benefit at statutory U.S. federal rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">406,343</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 10%; text-align: right">586,728</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ForeignIncomeTaxExpenseBenefitContinuingOperations_i_pp0p0" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left; padding-left: 2.75pt">Income tax benefit attributable to U.S. states</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">67,259</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right">99,325</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--ResearchAndDevelopmentCredits_zBOXKVQ07Gm6" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left; padding-left: 2.75pt">Research and development credits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(66,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right">137,728</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--NontaxableForgivenessOfPppAndEidlLoans_i_pp0p0" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left; padding-left: 2.75pt">Non-taxable forgiveness of PPP and EIDL loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0539">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right">20,478</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--NondeductibleExpenses_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left; padding-left: 2.75pt">Non-deductible expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(299</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(300</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--StockOptionPlanExpense_i_pp0p0" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left; padding-left: 2.75pt">Stock- based compensation related to incentive stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(47,290</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(53,952</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--OtherComprehensiveIncomeLossNetOfTax_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="padding-left: 2.75pt">Other changes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(7,439</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(15,182</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_i_pp0p0" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 2.75pt">Change in valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(352,574</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(774,825</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredIncomeTaxesAndTaxCredits_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.7pt"> Total income tax expense (benefit)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0554">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0555">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock> | |||||||||||||||||||||
<us-gaap:IncomeTaxReconciliationDispositionOfBusiness contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 406343 </us-gaap:IncomeTaxReconciliationDispositionOfBusiness> | |||||||||||||||||||||
<us-gaap:IncomeTaxReconciliationDispositionOfBusiness contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 586728 </us-gaap:IncomeTaxReconciliationDispositionOfBusiness> | |||||||||||||||||||||
<us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 67259 </us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations> | |||||||||||||||||||||
<us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 99325 </us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations> | |||||||||||||||||||||
<fnam:ResearchAndDevelopmentCredits contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> -66000 </fnam:ResearchAndDevelopmentCredits> | |||||||||||||||||||||
<fnam:ResearchAndDevelopmentCredits contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 137728 </fnam:ResearchAndDevelopmentCredits> | |||||||||||||||||||||
<fnam:NontaxableForgivenessOfPppAndEidlLoans contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 20478 </fnam:NontaxableForgivenessOfPppAndEidlLoans> | |||||||||||||||||||||
<fnam:NondeductibleExpenses contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> -299 </fnam:NondeductibleExpenses> | |||||||||||||||||||||
<fnam:NondeductibleExpenses contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> -300 </fnam:NondeductibleExpenses> | |||||||||||||||||||||
<us-gaap:StockOptionPlanExpense contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> -47290 </us-gaap:StockOptionPlanExpense> | |||||||||||||||||||||
<us-gaap:StockOptionPlanExpense contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> -53952 </us-gaap:StockOptionPlanExpense> | |||||||||||||||||||||
<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> -7439 </us-gaap:OtherComprehensiveIncomeLossNetOfTax> | |||||||||||||||||||||
<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> -15182 </us-gaap:OtherComprehensiveIncomeLossNetOfTax> | |||||||||||||||||||||
<us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> -352574 </us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance> | |||||||||||||||||||||
<us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> -774825 </us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance> | |||||||||||||||||||||
<us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2022-01-01to2022-12-31"> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zUPnLXvHtc5i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B4_z3qQ94rrFGE2" style="display: none">Schedule of deferred tax assets and liabilities</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20221231_zGv5IITw0A7c" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td> <td id="xdx_497_20211231_ze3yjKrD5R67" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: center"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left">Deferred income tax assets:</td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td> <td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0" style="vertical-align: bottom"> <td style="width: 74%; text-align: left"> Net operating loss carryforwards</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">2,928,442</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 10%; text-align: right">2,876,543</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left"> Research and development credits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">449,981</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right">515,982</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_i01I_pp0p0_zAWvXnDCy0D9" style="vertical-align: bottom"> <td style="text-align: left"> Accrued Compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0569">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--LongtermCapitalLossCarryforward_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left"> Long-term capital loss carryforward</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">94,445</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td> <td style="text-align: right">94,728</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di_z8bJBz1LDnHh" style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt"> Valuation allowance for deferred income tax assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,187,682</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(2,835,108</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left; padding-bottom: 1pt"> Net deferred income tax assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">308,853</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">652,145</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left">Deferred income tax liabilities:</td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td> <td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_i01NI_pp0p0_di_zTE3FwEE4d1g" style="vertical-align: bottom; background-color: transparent"> <td style="width: 74%; text-align: left"> Intangible assets</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">(307,885</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 10%; text-align: right">(647,554</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentOther_i01NI_pp0p0_di_zqDteaSGXBNj" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left; padding-bottom: 1pt"> Property, equipment and other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(968</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(4,591</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--DeferredIncomeTaxLiabilities_i01NI_pp0p0_di_zJg2PVwC2oQi" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left; padding-bottom: 1pt"> Total deferred income tax liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(308,853</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(652,145</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxLiabilities_iNI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left; padding-bottom: 2.5pt">Net deferred income tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0592">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0593">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock> | |||||||||||||||||||||
<us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 2928442 </us-gaap:DeferredTaxAssetsOperatingLossCarryforwards> | |||||||||||||||||||||
<us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 2876543 </us-gaap:DeferredTaxAssetsOperatingLossCarryforwards> | |||||||||||||||||||||
<us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 449981 </us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch> | |||||||||||||||||||||
<us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 515982 </us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch> | |||||||||||||||||||||
<us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 23667 </us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits> | |||||||||||||||||||||
<fnam:LongtermCapitalLossCarryforward contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 94445 </fnam:LongtermCapitalLossCarryforward> | |||||||||||||||||||||
<fnam:LongtermCapitalLossCarryforward contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 94728 </fnam:LongtermCapitalLossCarryforward> | |||||||||||||||||||||
<us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 3187682 </us-gaap:DeferredTaxAssetsValuationAllowance> | |||||||||||||||||||||
<us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 2835108 </us-gaap:DeferredTaxAssetsValuationAllowance> | |||||||||||||||||||||
<us-gaap:DeferredTaxAssetsNet contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 308853 </us-gaap:DeferredTaxAssetsNet> | |||||||||||||||||||||
<us-gaap:DeferredTaxAssetsNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 652145 </us-gaap:DeferredTaxAssetsNet> | |||||||||||||||||||||
<us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 307885 </us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets> | |||||||||||||||||||||
<us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 647554 </us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets> | |||||||||||||||||||||
<us-gaap:PropertyPlantAndEquipmentOther contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 968 </us-gaap:PropertyPlantAndEquipmentOther> | |||||||||||||||||||||
<us-gaap:PropertyPlantAndEquipmentOther contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 4591 </us-gaap:PropertyPlantAndEquipmentOther> | |||||||||||||||||||||
<us-gaap:DeferredIncomeTaxLiabilities contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 308853 </us-gaap:DeferredIncomeTaxLiabilities> | |||||||||||||||||||||
<us-gaap:DeferredIncomeTaxLiabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 652145 </us-gaap:DeferredIncomeTaxLiabilities> | |||||||||||||||||||||
<us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 3188000 </us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount> | |||||||||||||||||||||
<us-gaap:OperatingLossCarryforwards contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 11965000 </us-gaap:OperatingLossCarryforwards> | |||||||||||||||||||||
<us-gaap:OperatingLossCarryforwards contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 5545000 </us-gaap:OperatingLossCarryforwards> | |||||||||||||||||||||
<fnam:IndefiniteCarryforward contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 6420000 </fnam:IndefiniteCarryforward> | |||||||||||||||||||||
<fnam:CapitalLossCredits contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 386000 </fnam:CapitalLossCredits> | |||||||||||||||||||||
<us-gaap:TaxCreditCarryforwardAmount contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 450000 </us-gaap:TaxCreditCarryforwardAmount> | |||||||||||||||||||||
<us-gaap:DebtDisclosureTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_804_eus-gaap--DebtDisclosureTextBlock_zfnF2fA0uYDb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Note 7: <span id="xdx_82D_zfCOkubjrxMb">Notes Payable</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"><span style="text-decoration: underline">Small Business Administration (“SBA”) Paycheck Protection Program:</span> On February 22, 2021, the Company received $<span id="xdx_902_eus-gaap--ProceedsFromNotesPayable_pp0p0_c20210201__20210222__us-gaap--DebtInstrumentAxis__custom--SBAPaycheckProtectionProgramMember_zxujfaCXv0T2" title="Proceeds">76,395</span> in proceeds from the PPP, which was created under the Coronavirus Aid, Relief and Economic Security Act (CARES). Under the program, the Company applied for and received forgiveness of the debt in the year ended December 31, 2021. The forgiveness was recorded as loan forgiveness in other income on the consolidated statements of operations in the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"><span style="text-decoration: underline">SBA Economic Injury Disaster Loan:</span> On June 5, 2020, the Company received $<span id="xdx_906_eus-gaap--ProceedsFromNotesPayable_pp0p0_c20200604__20200605__us-gaap--DebtInstrumentAxis__custom--EIDLProgramMember_zuYa3IgdqdX1" title="Proceeds">150,000</span> in proceeds from the SBA’s EIDL Program. On July 20, 2021, the Company received an additional $<span id="xdx_90C_eus-gaap--ProceedsFromNotesPayable_pp0p0_c20210701__20210720__us-gaap--DebtInstrumentAxis__custom--EconomicInjuryDisasterLoanMember_zWtOSzQpWc31" title="Proceeds">7,000</span> SBA EIDL Advance which has been forgiven and, on July 14, 2021, the Company received a $<span id="xdx_905_eus-gaap--ProceedsFromNotesPayable_c20210701__20210714__us-gaap--DebtInstrumentAxis__custom--EIDLProgramMember_pp0p0" title="Proceeds">50,000</span> increase in the SBA EIDL Loan. Installment payments, including interest at the rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20200605__us-gaap--DebtInstrumentAxis__custom--EIDLProgramMember_zc0Gm9JbBhW6" title="Interest rate">3.75</span>% per annum, of $<span id="xdx_90A_eus-gaap--DebtInstrumentPeriodicPayment_c20200604__20200605__us-gaap--DebtInstrumentAxis__custom--EIDLProgramMember_pp0p0" title="Monthly payment">1,019</span> monthly over thirty years from the date of the original promissory note began on December 13, 2022. The Company granted to the SBA a continuing security interest in all tangible and intangible personal property. The Company may not make any distribution of assets of the Company to any shareholder without the written consent of the SBA. As of December 31, 2022, the Company recognized $<span id="xdx_901_eus-gaap--InterestPayableCurrent_c20221231__us-gaap--DebtInstrumentAxis__custom--EIDLProgramMember_pp0p0" title="Accrued interest">16,128</span> of accrued interest on the note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"><span style="text-decoration: underline">Dole Food Company:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"><span id="a_Hlk55191561"/> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt">On August 19, 2020, the Company entered into a Development and Commercialization Agreement (“DCA”) with Dole Food Company (“Dole”) for the development of our banana genes. The DCA provides for payments from Dole to the Company of $<span id="xdx_906_ecustom--PaymentToCompanyUponExecution_c20200819__us-gaap--DebtInstrumentAxis__custom--DCADoleMember_pp0p0" title="Payment upon execution">800,000</span> upon execution, $<span id="xdx_90C_ecustom--PaymentToCompanyByTwelveMonthAnniversary_c20200819__us-gaap--DebtInstrumentAxis__custom--DCADoleMember_pp0p0" title="Payment twelve-month anniversary">800,000</span> by the twelve-month anniversary, $<span id="xdx_900_ecustom--PaymentToCompanyByThirtySxMonthAnniversary_c20200819__us-gaap--DebtInstrumentAxis__custom--DCADoleMember_pp0p0" title="Payment thirty six month anniversary">250,000</span> by the thirty-six month anniversary and $<span id="xdx_906_ecustom--PaymentToCompanyByFortyEightMonthAnniversary_c20200819__us-gaap--DebtInstrumentAxis__custom--DCADoleMember_pp0p0" title="Payment forty eight month anniversary">250,000</span> by the forty-eight month anniversary. Dole also reimburses the Company for costs incurred at the University of Wisconsin-Madison (“UW”) not to exceed $<span id="xdx_90C_ecustom--ReimbursedCostsIncurred_c20200819__us-gaap--DebtInstrumentAxis__custom--DCADoleMember_pp0p0" title="Reimbursement of costs">2,200,000</span> in coordination with the Standard Research Agreement that the Company entered into with UW on September 18, 2020. The agreement with UW includes payments from the Company to UW in the amount of $<span id="xdx_906_ecustom--ExpectedPaymentsToUnversityOfWisconsinMadisonTwoYearTerm_c20200819__us-gaap--DebtInstrumentAxis__custom--ResearchAgreementUniversityOfWisconsinMadisonMember_pp0p0" title="Expected payments University of Wisconsin-Madison">2,159,719</span> over the two-year expected term of the project. If the UW research is successful, Dole expects to incur costs of approximately $<span id="xdx_904_ecustom--ExpectedFieldTrialCosts_iI_pp0p0_c20200819__us-gaap--DebtInstrumentAxis__custom--DCADoleMember_zrMpcaTsAb8h" title="Expected field trial costs">750,000</span> to perform field trials.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt">The DCA also specifies that the Company will execute notes payable to Dole for the funding that Dole is providing up to $<span id="xdx_90D_ecustom--NotesPayableForDoleFunding_c20200819__us-gaap--DebtInstrumentAxis__custom--DCADoleMember_pp0p0" title="Notes payable for dole funding">5,050,000</span>. Upon receipt of $<span id="xdx_90F_ecustom--PaymentUponReceipt_c20200826__us-gaap--DebtInstrumentAxis__custom--DCADoleMember_pp0p0" title="Payment upon receipt">800,000</span> on August 26, 2020, $<span id="xdx_900_ecustom--PaymentUponReceipt_c20210728__us-gaap--DebtInstrumentAxis__custom--DCADoleMember_pp0p0" title="Payment upon receipt">800,000</span> on July 28, 2021, $<span id="xdx_901_ecustom--PaymentUponReceipt_iI_pp0p0_c20201229__us-gaap--DebtInstrumentAxis__custom--DCADoleMember_zPuJpMj5XYQg" title="Payment upon receipt">1,295,831</span> on December 29, 2020 and $<span id="xdx_90E_ecustom--PaymentUponReceipt_iI_pp0p0_c20210929__us-gaap--DebtInstrumentAxis__custom--DCADoleMember_zRWvib0VAwJ8" title="Payment upon receipt">647,916</span> on September 29, 2021, the Company executed the notes under this DCA and recorded them as long-term notes payable for financial statement purposes. The notes are non-interest bearing and allow Dole to offset fifty percent of future royalty payments to the Company by reducing the amount of principal due on these notes. Other than this offset of future royalty payments, repayment of principal and interest is only required in the case of termination of the DCA by Dole for cause.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"> </span></p> </us-gaap:DebtDisclosureTextBlock> | |||||||||||||||||||||
<us-gaap:ProceedsFromNotesPayable contextRef="From2021-02-012021-02-22_custom_SBAPaycheckProtectionProgramMember" decimals="0" unitRef="USD"> 76395 </us-gaap:ProceedsFromNotesPayable> | |||||||||||||||||||||
<us-gaap:ProceedsFromNotesPayable contextRef="From2020-06-042020-06-05_custom_EIDLProgramMember" decimals="0" unitRef="USD"> 150000 </us-gaap:ProceedsFromNotesPayable> | |||||||||||||||||||||
<us-gaap:ProceedsFromNotesPayable contextRef="From2021-07-012021-07-20_custom_EconomicInjuryDisasterLoanMember" decimals="0" unitRef="USD"> 7000 </us-gaap:ProceedsFromNotesPayable> | |||||||||||||||||||||
<us-gaap:ProceedsFromNotesPayable contextRef="From2021-07-012021-07-14_custom_EIDLProgramMember" decimals="0" unitRef="USD"> 50000 </us-gaap:ProceedsFromNotesPayable> | |||||||||||||||||||||
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2020-06-05_custom_EIDLProgramMember" decimals="INF" unitRef="Pure"> 0.0375 </us-gaap:DebtInstrumentInterestRateStatedPercentage> | |||||||||||||||||||||
<us-gaap:DebtInstrumentPeriodicPayment contextRef="From2020-06-042020-06-05_custom_EIDLProgramMember" decimals="0" unitRef="USD"> 1019 </us-gaap:DebtInstrumentPeriodicPayment> | |||||||||||||||||||||
<us-gaap:InterestPayableCurrent contextRef="AsOf2022-12-31_custom_EIDLProgramMember" decimals="0" unitRef="USD"> 16128 </us-gaap:InterestPayableCurrent> | |||||||||||||||||||||
<fnam:PaymentToCompanyUponExecution contextRef="AsOf2020-08-19_custom_DCADoleMember" decimals="0" unitRef="USD"> 800000 </fnam:PaymentToCompanyUponExecution> | |||||||||||||||||||||
<fnam:PaymentToCompanyByTwelveMonthAnniversary contextRef="AsOf2020-08-19_custom_DCADoleMember" decimals="0" unitRef="USD"> 800000 </fnam:PaymentToCompanyByTwelveMonthAnniversary> | |||||||||||||||||||||
<fnam:PaymentToCompanyByThirtySxMonthAnniversary contextRef="AsOf2020-08-19_custom_DCADoleMember" decimals="0" unitRef="USD"> 250000 </fnam:PaymentToCompanyByThirtySxMonthAnniversary> | |||||||||||||||||||||
<fnam:PaymentToCompanyByFortyEightMonthAnniversary contextRef="AsOf2020-08-19_custom_DCADoleMember" decimals="0" unitRef="USD"> 250000 </fnam:PaymentToCompanyByFortyEightMonthAnniversary> | |||||||||||||||||||||
<fnam:ReimbursedCostsIncurred contextRef="AsOf2020-08-19_custom_DCADoleMember" decimals="0" unitRef="USD"> 2200000 </fnam:ReimbursedCostsIncurred> | |||||||||||||||||||||
<fnam:ExpectedPaymentsToUnversityOfWisconsinMadisonTwoYearTerm contextRef="AsOf2020-08-19_custom_ResearchAgreementUniversityOfWisconsinMadisonMember" decimals="0" unitRef="USD"> 2159719 </fnam:ExpectedPaymentsToUnversityOfWisconsinMadisonTwoYearTerm> | |||||||||||||||||||||
<fnam:ExpectedFieldTrialCosts contextRef="AsOf2020-08-19_custom_DCADoleMember" decimals="0" unitRef="USD"> 750000 </fnam:ExpectedFieldTrialCosts> | |||||||||||||||||||||
<fnam:NotesPayableForDoleFunding contextRef="AsOf2020-08-19_custom_DCADoleMember" decimals="0" unitRef="USD"> 5050000 </fnam:NotesPayableForDoleFunding> | |||||||||||||||||||||
<fnam:PaymentUponReceipt contextRef="AsOf2020-08-26_custom_DCADoleMember" decimals="0" unitRef="USD"> 800000 </fnam:PaymentUponReceipt> | |||||||||||||||||||||
<fnam:PaymentUponReceipt contextRef="AsOf2021-07-28_custom_DCADoleMember" decimals="0" unitRef="USD"> 800000 </fnam:PaymentUponReceipt> | |||||||||||||||||||||
<fnam:PaymentUponReceipt contextRef="AsOf2020-12-29_custom_DCADoleMember" decimals="0" unitRef="USD"> 1295831 </fnam:PaymentUponReceipt> | |||||||||||||||||||||
<fnam:PaymentUponReceipt contextRef="AsOf2021-09-29_custom_DCADoleMember" decimals="0" unitRef="USD"> 647916 </fnam:PaymentUponReceipt> | |||||||||||||||||||||
<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_80B_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z8J8VR9Na8e2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Note 8: <span id="xdx_820_zeti59l0VLb5">Stockholders’ Equity</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt">The Amended and Restated Certificate of Incorporation of the Company dated October 19, 2015 authorized the issuance of <span id="xdx_90A_ecustom--CapitalStockSharesAuthorized_c20151019_pdd" title="Capital stock, authorized shares">800,000,000</span> shares of all classes of stock including <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_c20151019_pdd" title="Common stock, authorized shares">780,000,000</span> shares of Common Stock having a par value of $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_c20151019_pdd" title="Common stock, par value">0.001</span> per share and <span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_c20151019_pdd" title="Preferred stock, authorized shares">20,000,000</span> shares of Preferred Stock having a par value of $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_c20151019__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_pdd" title="Preferred stock, par value">0.001</span> per share, <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_c20151019__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_pdd" title="Preferred stock, authorized shares">600,000</span> of which were designated as Series A-1 Convertible Preferred Stock (“Series A-1”) and <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_c20151019__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesA2Member_pdd" title="Preferred stock, authorized shares">200,000</span> of which were designated as Series A-2 Convertible Preferred Stock (“Series A-2”). The Board of Directors, without a vote of the shareholders, is authorized to issue additional shares of Preferred Stock in series and to establish the characteristics thereof.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"><span style="text-decoration: underline">Liquidation</span>: Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, the holders of the Series A-1 and Series A-2 shall be entitled to receive out of the assets of the Company for each share of Series A-1 and Series A-2 an amount equal to its stated value, $<span id="xdx_90A_ecustom--StatedPerShareValueOfPreferredStock_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesA2PreferredStockMember_pdd" title="Stated per share value of preferred stock"><span id="xdx_90B_ecustom--StatedPerShareValueOfPreferredStock_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--SeriesA2PreferredStockMember_z5kNKRoPavF" title="Stated per share value of preferred stock">5.25</span></span> per share as of December 31, 2022 and 2021, plus any accrued but unpaid dividends before any distribution or payment shall be made to the holders of any other class or series of stock of the Company that ranks junior to the Series A-1 and Series A-2. The holders shall be entitled to convert their shares of Series A-1 and Series A-2 into Common Stock at any time prior to the consummation of a Liquidation. This is considered a contingent redemption feature.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"><span style="text-decoration: underline">Conversion</span>: The holders of Series A-1 and Series A-2 may convert their shares into shares of Common Stock, at the option of the holder, on a one-share-for-one-share basis and shall be subject to certain adjustments at any time.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"><span style="text-decoration: underline">Optional Redemption; Sinking Fund Account:</span> The Company may elect to redeem some or all of the then outstanding shares of Series A-1, (i) for cash in an amount equal to the liquidation preference per share, $<span id="xdx_90D_ecustom--StatedPerShareValueOfPreferredStock_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Stated per share value of preferred stock"><span id="xdx_90C_ecustom--StatedPerShareValueOfPreferredStock_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Stated per share value of preferred stock">5.25</span></span> per share as of December 31, 2022, subject to adjustment and (ii) by issuing one share, subject to adjustment, of Common Stock for each share of Series A-1 and Series A-2 outstanding being redeemed. 50% of all licensing fees received by the Company will be deposited into a separate sinking fund for use in an optional redemption. As of December 31, 2022, no licensing revenue has been received under these provisions and no sinking fund account has been established.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"><span style="text-decoration: underline">Dividends</span>: The Company shall pay to the holders of the Series A-1 and Series A-2 dividends at the rate of <span id="xdx_907_eus-gaap--PreferredStockDividendRatePercentage_dp_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesA2Member_zb4TsrwavVui" title="Dividend rate"><span id="xdx_903_eus-gaap--PreferredStockDividendRatePercentage_dp_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_ze5zyaraojE4" title="Dividend rate">8</span></span>% per annum and the Company has accrued these dividends since issuance of the Series A-1 and Series A-2. The dividend amount shall accrue and shall be payable in shares of Common Stock upon the conversion of the Series A-1 and Series A-2, or upon the redemption of the Series A-1 and Series A-2. No dividends shall be paid on any Common Stock of the Company or any capital stock of the Company that ranks junior to the Series A-1 and Series A-2 until dividends of Series A-1 and Series A-2 been paid. As of December 31, 2022, there were $<span id="xdx_902_eus-gaap--DividendsPayableCurrent_c20221231_pp0p0" title="Dividends accrued">1,835,089</span> in accrued stock dividends.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-size: 10pt"><span style="text-decoration: underline">Voting</span>: The holders of the Series A-1 and Series A-2 are entitled to vote on all matters submitted to the stockholders for a vote on an as-if-converted to Common Stock basis, with all stockholders voting as a single class.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"> </span></p> </us-gaap:StockholdersEquityNoteDisclosureTextBlock> | |||||||||||||||||||||
<fnam:CapitalStockSharesAuthorized contextRef="AsOf2015-10-19" decimals="INF" unitRef="Shares"> 800000000 </fnam:CapitalStockSharesAuthorized> | |||||||||||||||||||||
<us-gaap:CommonStockSharesAuthorized contextRef="AsOf2015-10-19" decimals="INF" unitRef="Shares"> 780000000 </us-gaap:CommonStockSharesAuthorized> | |||||||||||||||||||||
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2015-10-19" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:CommonStockParOrStatedValuePerShare> | |||||||||||||||||||||
<us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2015-10-19" decimals="INF" unitRef="Shares"> 20000000 </us-gaap:PreferredStockSharesAuthorized> | |||||||||||||||||||||
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2015-10-19_us-gaap_ConvertiblePreferredStockMember" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare> | |||||||||||||||||||||
<us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2015-10-19_us-gaap_ConvertiblePreferredStockMember" decimals="INF" unitRef="Shares"> 600000 </us-gaap:PreferredStockSharesAuthorized> | |||||||||||||||||||||
<us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2015-10-19_custom_ConvertiblePreferredStockSeriesA2Member" decimals="INF" unitRef="Shares"> 200000 </us-gaap:PreferredStockSharesAuthorized> | |||||||||||||||||||||
<fnam:StatedPerShareValueOfPreferredStock contextRef="AsOf2022-12-31_custom_SeriesA2PreferredStockMember" decimals="INF" unitRef="USDPShares"> 5.25 </fnam:StatedPerShareValueOfPreferredStock> | |||||||||||||||||||||
<fnam:StatedPerShareValueOfPreferredStock contextRef="AsOf2021-12-31_custom_SeriesA2PreferredStockMember" decimals="INF" unitRef="USDPShares"> 5.25 </fnam:StatedPerShareValueOfPreferredStock> | |||||||||||||||||||||
<fnam:StatedPerShareValueOfPreferredStock contextRef="AsOf2022-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="USDPShares"> 5.25 </fnam:StatedPerShareValueOfPreferredStock> | |||||||||||||||||||||
<fnam:StatedPerShareValueOfPreferredStock contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="USDPShares"> 5.25 </fnam:StatedPerShareValueOfPreferredStock> | |||||||||||||||||||||
<us-gaap:PreferredStockDividendRatePercentage contextRef="From2022-01-012022-12-31_custom_ConvertiblePreferredStockSeriesA2Member" decimals="INF" unitRef="Pure"> 0.08 </us-gaap:PreferredStockDividendRatePercentage> | |||||||||||||||||||||
<us-gaap:PreferredStockDividendRatePercentage contextRef="From2022-01-012022-12-31_us-gaap_ConvertiblePreferredStockMember" decimals="INF" unitRef="Pure"> 0.08 </us-gaap:PreferredStockDividendRatePercentage> | |||||||||||||||||||||
<us-gaap:DividendsPayableCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 1835089 </us-gaap:DividendsPayableCurrent> | |||||||||||||||||||||
<us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_802_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zIv0fhIGsjAf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Note 9: <span id="xdx_82A_zTZi4hclGyIl">Stock-Based Compensation</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">The Company grants stock-based instruments under the 2015 Stock Incentive Plan (“Plan”) for which <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c20221231_pdd" title="Number of shares reserved for issuance under 2015 Stock Incentive Plan">1,400,000</span> shares of the Company’s Common Stock has been reserved. The Plan allows for the issuance of incentive stock options and non-qualified stock options with a maximum contractual term of <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20220101__20221231_z6WicX51Sm26" title="Expiration period for stock options">10</span> years. Shares and options that are cancelled are available for reissuance under the Plan. For years ended December 31, 2022 and 2021, the Company recorded compensation costs for stock options of $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20220101__20221231_pp0p0" title="Compensation costs for stock options">193,208</span> and $<span id="xdx_902_eus-gaap--ShareBasedCompensation_c20210101__20211231_pp0p0" title="Compensation costs for stock options">219,718</span>, respectively. Stock options are generally issued with an exercise price at or above the estimated per-share value of the Company’s Common Stock. The Company granted options for <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20221231_pdd" title="Stock options granted during period">133,333</span> shares of common stock during the year ended December 31, 2022 and <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_dn_c20210101__20211231_zE9hTEnMTz3f" title="Stock options granted during period">none</span> in the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">Management has valued the options at their date of grant utilizing the Black-Scholes option pricing model. Volatility of the underlying common shares was determined based on the historical volatility for the Company’s stock for a term consistent with the expected life of the options. The risk-free interest rate used in the calculations is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the options on the date of the grant. Due to the lack of sufficient historical activity, the expected term of the options was estimated using the formula set forth in Securities and Exchange Commission SAB 107.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">The fair value of the share option awards was estimated using the Black-Scholes method based on the following weighted-average assumptions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleWeightedAverageAssumptionsTableTextBlock_zlUY3xiddQjg" style="margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto" summary="xdx: Disclosure - Stock-Based Compensation (Details)"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span id="xdx_8B8_ztpMjysbFrRj" style="display: none">Schedule Weighted Average Assumptions</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 70%"><span style="font-size: 10pt">Volatility</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 30%; text-align: center"><span style="font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20221231_zgghTrkBIW3f" title="Volatility">154</span>%</span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-size: 10pt">Expected Term</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-size: 10pt"> <span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231_zEzTL1fZBYZ9" title="Expected Term">5.5</span> years</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-size: 10pt">Dividend Rate</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220101__20221231_zw0JwY0yONa5" title="Dividend Rate">0</span>%</span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-size: 10pt">Risk Free Rate</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20221231_zFPKdEhZ6gOe" title="Risk Free Rate">2.56</span>%</span></td></tr> </table> <p id="xdx_8AA_ztbiKUP1Nv0g" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">The following table summarizes the status of the Company’s aggregate stock options granted:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zsz2B9pPYnxh" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock-Based Compensation (Details 1)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span id="xdx_8B7_zzBeiMjTdcu" style="display: none">Schedule of Stock Option Activity</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; font-size: 10pt; vertical-align: top"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Options</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Remaining Term (Years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total Intrinsic Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; font-size: 10pt; vertical-align: top"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 40%; text-align: left"><span style="font-size: 10pt">Balance, January 1, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zSYWuxLcIeld" style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right" title="Number of Options, Beginning">1,081,667</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zohFTuVIpjUc" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Average Exercise Price, Beginning">1.74</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_z8Nnopqy82f4" title="Outstanding beginning, contractual term">6.67</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 10%; font-size: 10pt; text-align: right"> </td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231_zZGbbfskf98i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0709">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0711">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20211231_ztrhx0hSQlZ3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0713">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0715">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Cancelled</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20211231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl0717">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl0719">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="vertical-align: top; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Balance, December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_zyezQayzbOB2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Ending">1,081,667</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_z2MyoLnEB1O" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending">1.74</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20211231_z0EYOmpXD2Wc" title="Outstanding ending, contractual term">5.67</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="vertical-align: top; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Balance, January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_zuhqykAvobgd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Beginning">1,081,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zxTleTmAzrq3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Beginning">1.74</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zqJ4AEXDhZ32" title="Outstanding beginning, contractual term">5.67</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted">133,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted">0.83</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zlvfXZDdlY25" title="Weighted average remaining term, granted">9.23</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20221231_zk14frRZUC4j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised">(186,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised">0.55</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Cancelled</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl0743">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl0745">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="vertical-align: top; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Balance, December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231_zu7t9LjfZmO7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Ending">1,028,333</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231_z24ZjtQfDFO5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending">1.84</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20220101__20221231_zSHO8pCjI4m3" title="Outstanding ending, contractual term">6.22</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="vertical-align: top; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Exercisable at December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231_pdd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercisable">861,664</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231_pdd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercisable">2.00</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zBbHYlUKcQ5b" title="Exercisable, contractual term">5.73</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_c20221231_zRtArCCD8lel" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable, Intrinsic value"><span style="-sec-ix-hidden: xdx2ixbrl0759">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zWYukz4zV4r9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">During the years ended December 31, 2022 and 2021, options for <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231_pdd" title="Number of shares vested during the period">179,999</span> and <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20211231_pdd" title="Number of shares vested during the period">180,000</span> shares vested, respectively. As of December 31, 2022, there was $<span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c20221231_pp0p0" title="Unrecognized compensation cost related to share-based compensation arrangements">85,548</span> unrecognized compensation cost related to share-based compensation arrangements that will be recognized through the year ending December 31, 2023.<span id="a_Aci_Pg45"/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares"> 1400000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized> | |||||||||||||||||||||
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2022-01-01to2022-12-31"> P10Y </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensation contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 193208 </us-gaap:ShareBasedCompensation> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensation contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 219718 </us-gaap:ShareBasedCompensation> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2022-01-01to2022-12-31" decimals="INF" unitRef="Shares"> 133333 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2021-01-012021-12-31" decimals="INF" unitRef="Shares"> 0 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod> | |||||||||||||||||||||
<fnam:ScheduleWeightedAverageAssumptionsTableTextBlock contextRef="From2022-01-01to2022-12-31"> <table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleWeightedAverageAssumptionsTableTextBlock_zlUY3xiddQjg" style="margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto" summary="xdx: Disclosure - Stock-Based Compensation (Details)"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span id="xdx_8B8_ztpMjysbFrRj" style="display: none">Schedule Weighted Average Assumptions</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 70%"><span style="font-size: 10pt">Volatility</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 30%; text-align: center"><span style="font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20221231_zgghTrkBIW3f" title="Volatility">154</span>%</span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-size: 10pt">Expected Term</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-size: 10pt"> <span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231_zEzTL1fZBYZ9" title="Expected Term">5.5</span> years</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-size: 10pt">Dividend Rate</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220101__20221231_zw0JwY0yONa5" title="Dividend Rate">0</span>%</span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-size: 10pt">Risk Free Rate</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20221231_zFPKdEhZ6gOe" title="Risk Free Rate">2.56</span>%</span></td></tr> </table> </fnam:ScheduleWeightedAverageAssumptionsTableTextBlock> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2022-01-01to2022-12-31" decimals="INF" unitRef="Pure"> 1.54 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate> | |||||||||||||||||||||
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2022-01-01to2022-12-31"> P5Y6M </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2022-01-01to2022-12-31" decimals="INF" unitRef="Pure"> 0 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2022-01-01to2022-12-31" decimals="INF" unitRef="Pure"> 0.0256 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate> | |||||||||||||||||||||
<us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2022-01-01to2022-12-31"> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zsz2B9pPYnxh" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock-Based Compensation (Details 1)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span id="xdx_8B7_zzBeiMjTdcu" style="display: none">Schedule of Stock Option Activity</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; font-size: 10pt; vertical-align: top"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Options</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Remaining Term (Years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total Intrinsic Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; font-size: 10pt; vertical-align: top"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 40%; text-align: left"><span style="font-size: 10pt">Balance, January 1, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zSYWuxLcIeld" style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right" title="Number of Options, Beginning">1,081,667</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zohFTuVIpjUc" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Average Exercise Price, Beginning">1.74</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_z8Nnopqy82f4" title="Outstanding beginning, contractual term">6.67</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 10%; font-size: 10pt; text-align: right"> </td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231_zZGbbfskf98i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0709">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0711">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20211231_ztrhx0hSQlZ3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0713">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0715">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Cancelled</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20211231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl0717">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl0719">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="vertical-align: top; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Balance, December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_zyezQayzbOB2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Ending">1,081,667</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_z2MyoLnEB1O" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending">1.74</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20211231_z0EYOmpXD2Wc" title="Outstanding ending, contractual term">5.67</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="vertical-align: top; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Balance, January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_zuhqykAvobgd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Beginning">1,081,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zxTleTmAzrq3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Beginning">1.74</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zqJ4AEXDhZ32" title="Outstanding beginning, contractual term">5.67</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted">133,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted">0.83</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zlvfXZDdlY25" title="Weighted average remaining term, granted">9.23</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20221231_zk14frRZUC4j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised">(186,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised">0.55</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Cancelled</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl0743">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl0745">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="vertical-align: top; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Balance, December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231_zu7t9LjfZmO7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Ending">1,028,333</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231_z24ZjtQfDFO5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending">1.84</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20220101__20221231_zSHO8pCjI4m3" title="Outstanding ending, contractual term">6.22</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="vertical-align: top; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-size: 10pt">Exercisable at December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231_pdd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercisable">861,664</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231_pdd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercisable">2.00</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zBbHYlUKcQ5b" title="Exercisable, contractual term">5.73</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_c20221231_zRtArCCD8lel" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable, Intrinsic value"><span style="-sec-ix-hidden: xdx2ixbrl0759">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares"> 1081667 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-12-31" decimals="INF" unitRef="USDPShares"> 1.74 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice> | |||||||||||||||||||||
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-012021-12-31"> P6Y8M1D </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares"> 1081667 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2021-12-31" decimals="INF" unitRef="USDPShares"> 1.74 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice> | |||||||||||||||||||||
<fnam:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2021-01-012021-12-31"> P5Y8M1D </fnam:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares"> 1081667 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2021-12-31" decimals="INF" unitRef="USDPShares"> 1.74 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice> | |||||||||||||||||||||
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2022-01-01to2022-12-31"> P5Y8M1D </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2022-01-01to2022-12-31" decimals="INF" unitRef="Shares"> 133333 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2022-01-01to2022-12-31" decimals="INF" unitRef="USDPShares"> 0.83 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice> | |||||||||||||||||||||
<fnam:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2 contextRef="From2022-01-01to2022-12-31"> P9Y2M23D </fnam:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2> | |||||||||||||||||||||
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2022-01-01to2022-12-31" decimals="INF" unitRef="Shares"> 186667 </us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2022-01-01to2022-12-31" decimals="INF" unitRef="USDPShares"> 0.55 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares"> 1028333 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2022-12-31" decimals="INF" unitRef="USDPShares"> 1.84 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice> | |||||||||||||||||||||
<fnam:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2022-01-01to2022-12-31"> P6Y2M19D </fnam:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares"> 861664 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber> | |||||||||||||||||||||
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2022-12-31" decimals="INF" unitRef="USDPShares"> 2.00 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice> | |||||||||||||||||||||
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2022-01-01to2022-12-31"> P5Y8M23D </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1> | |||||||||||||||||||||
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2022-01-01to2022-12-31" decimals="INF" unitRef="Shares"> 179999 </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares> | |||||||||||||||||||||
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2021-01-012021-12-31" decimals="INF" unitRef="Shares"> 180000 </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares> | |||||||||||||||||||||
<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 85548 </us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions> | |||||||||||||||||||||
<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_803_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zws9HCpsw2tk" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Note 10: <span id="xdx_824_zN1rs3o4frtk">Commitments and Contingencies</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline">Officer Indemnification</span>: Under the Company’s organizational documents, the Company’s officers, employees, and directors are indemnified against certain liabilities arising out of the performance of their duties. The Company’s maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Company that have not yet occurred. However, based on experience, the Company expects any risk of loss to be remote. The Company also has an insurance policy for its directors and officers to insure them against liabilities arising from their performance in their positions with the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline">Lease Commitments</span>: The Company leases its operating facility and pays its rent in monthly installments. The lease was renewed in June 2016 for a period of twelve months and monthly rentals for the period of July 1, 2016 through December 31, 2022 are $<span id="xdx_901_ecustom--MonthlyRentPayment_c20221231_pp0p0" title="Monthly rent payment">2,378</span> per month which continues on a month-to-month basis. There is no minimum lease commitment as of December 31, 2022. Renewals after June 30, 2017 are by mutual agreement. The Company’s rent expense for the years ended December 31, 2022 and 2021 was $<span id="xdx_905_eus-gaap--LeaseAndRentalExpense_c20220101__20221231_pp0p0" title="Rent expense">26,157</span> and $<span id="xdx_903_eus-gaap--LeaseAndRentalExpense_c20210101__20211231_pp0p0" title="Rent expense">28,535</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline">Royalty</span>: Effective March 1, 2012, the Company entered into an Agreement for Contract Services with SmithBucklin Corporation (the “Contractor”) on behalf of the United Soybean Board. The contract includes the payment of certain royalties, as defined in the Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span id="a_Aci_Pg46"/>The Company is obligated to pay royalties to the United Soybean Board of 10% of the sale of products derived from the soybean genes that were the subject of the research performed by the Contractor or from royalties received by the Company from the sale of products by a third party not to exceed 150% of the total amount paid to the Contractor under this Agreement. The Company has recognized to date grant revenue from the contract of $<span id="xdx_90B_ecustom--TotalAmountOfGrantRevenueRecognizedToDate_c20221231_pp0p0" title="Total amount of grant revenue recognized to date">262,400</span> as of December 31, 2022, thus limiting any future royalties as of December 31, 2022 to a total of $<span id="xdx_901_ecustom--TotalPossibleFutureRoyaltiesOwed_c20221231_pp0p0" title="Total possible future royalties owed">393,600</span>. The Company has not accrued or paid any royalties under the terms of the Agreement as of and during the years ended December 31, 2022 and 2021 because it has not received any revenue from the sale of products to date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline">Other Commitments: </span>On September 18, 2020, the Company entered into a Standard Research Agreement with WCIC for the development of our banana genes. The agreement includes payments from the Company in the amount of $<span id="xdx_90D_eus-gaap--PaymentsForRoyalties_pp0p0_c20200901__20200918__us-gaap--TypeOfArrangementAxis__custom--StandardResearchAgreementMember_zxrKkUTQqI5e" title="Payments for royalties">2,159,719</span> over the <span id="xdx_90E_eus-gaap--DebtInstrumentTerm_dtY_c20200901__20200918__us-gaap--TypeOfArrangementAxis__custom--StandardResearchAgreementMember_zSIcIJPvrN85" style="display: none" title="Term">2</span> two-year expected term of the project. These costs will be reimbursed, in the form of notes payable by Dole in accordance with our DCA.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">The Company entered into a Service Agreement with WCIC for the maintenance and shipment of banana plants which includes unit pricing for services rendered and is expected to be completed by March 31, 2023. During the year ended December 31, 2022, $<span id="xdx_904_eus-gaap--CostsAndExpenses_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_zfpfc8KZ6aM6" title="Maintenance and shipment costs">59,330</span> of cost was incurred under this contract and was reimbursed by Dole.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">On April 18, 2022, the Company entered into a Service Agreement with the University of Wisconsin-Madison for the testing of banana plants which includes payments of $<span id="xdx_907_eus-gaap--OtherExpenses_c20220401__20220418__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_zkvpGJxc599i" title="Other expenses">143,124</span> of which $<span id="xdx_904_ecustom--PaymentToContractAmount_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_zBrFpiD2q5Kk" title="Payment to contract amount">128,811</span> were paid in the year ended December 31, 2022 and reimbursed by Dole.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b> </b></span></p> </us-gaap:CommitmentsAndContingenciesDisclosureTextBlock> | |||||||||||||||||||||
<fnam:MonthlyRentPayment contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 2378 </fnam:MonthlyRentPayment> | |||||||||||||||||||||
<us-gaap:LeaseAndRentalExpense contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 26157 </us-gaap:LeaseAndRentalExpense> | |||||||||||||||||||||
<us-gaap:LeaseAndRentalExpense contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 28535 </us-gaap:LeaseAndRentalExpense> | |||||||||||||||||||||
<fnam:TotalAmountOfGrantRevenueRecognizedToDate contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 262400 </fnam:TotalAmountOfGrantRevenueRecognizedToDate> | |||||||||||||||||||||
<fnam:TotalPossibleFutureRoyaltiesOwed contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 393600 </fnam:TotalPossibleFutureRoyaltiesOwed> | |||||||||||||||||||||
<us-gaap:PaymentsForRoyalties contextRef="From2020-09-012020-09-18_custom_StandardResearchAgreementMember" decimals="0" unitRef="USD"> 2159719 </us-gaap:PaymentsForRoyalties> | |||||||||||||||||||||
<us-gaap:DebtInstrumentTerm contextRef="From2020-09-012020-09-18_custom_StandardResearchAgreementMember"> P2Y </us-gaap:DebtInstrumentTerm> | |||||||||||||||||||||
<us-gaap:CostsAndExpenses contextRef="From2022-01-012022-12-31_custom_ServiceAgreementMember" decimals="0" unitRef="USD"> 59330 </us-gaap:CostsAndExpenses> | |||||||||||||||||||||
<us-gaap:OtherExpenses contextRef="From2022-04-012022-04-18_custom_ServiceAgreementMember" decimals="0" unitRef="USD"> 143124 </us-gaap:OtherExpenses> | |||||||||||||||||||||
<fnam:PaymentToContractAmount contextRef="From2022-01-012022-12-31_custom_ServiceAgreementMember" decimals="0" unitRef="USD"> 128811 </fnam:PaymentToContractAmount> | |||||||||||||||||||||
<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zNzwBy86zyA4" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Note 11: <span id="xdx_826_zZRA1djboW3">Related Parties and Transactions</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline">Steve B. Warnecke:</span> Mr. Warnecke is the Company’s Chief Executive Officer and Chairman of the Board and owns, directly or indirectly, <span id="xdx_902_ecustom--NumberOfCommonStockOutstandingOwnedByRelatedPartyShares_c20221231__us-gaap--RelatedPartyTransactionAxis__srt--ChiefExecutiveOfficerMember_pdd" title="Number of common stock shares outstanding owned by related party">1,841,374</span> shares or <span id="xdx_90A_ecustom--PercentageOfCommonStockSharesOutstandingOwnedByRelatedParty_iI_dp_c20221231__us-gaap--RelatedPartyTransactionAxis__srt--ChiefExecutiveOfficerMember_zc2CTdoFMyHg" title="Percentage of common stock shares outstanding owned by related party">24.8</span>% of the Common Stock outstanding as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:RelatedPartyTransactionsDisclosureTextBlock> | |||||||||||||||||||||
<fnam:NumberOfCommonStockOutstandingOwnedByRelatedPartyShares contextRef="AsOf2022-12-31_srt_ChiefExecutiveOfficerMember" decimals="INF" unitRef="Shares"> 1841374 </fnam:NumberOfCommonStockOutstandingOwnedByRelatedPartyShares> | |||||||||||||||||||||
<fnam:PercentageOfCommonStockSharesOutstandingOwnedByRelatedParty contextRef="AsOf2022-12-31_srt_ChiefExecutiveOfficerMember" decimals="INF" unitRef="Pure"> 0.248 </fnam:PercentageOfCommonStockSharesOutstandingOwnedByRelatedParty> | |||||||||||||||||||||
<us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_802_eus-gaap--ConcentrationRiskDisclosureTextBlock_z4Q7TdzCQSx7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Note 12: <span id="xdx_82D_zv2Ovok23nJ2">Concentrations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><span style="text-decoration: underline">Considerations of Credit Risk</span>: Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company maintains its cash balances at high-credit, quality financial institutions. The balances, at times, may exceed federally insured limits. The Company routinely monitors the credit quality of its customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:ConcentrationRiskDisclosureTextBlock> | |||||||||||||||||||||
<us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_807_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zW1gvJ5uEp64" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Note 13: <span id="xdx_825_zolCnU2T7Pd6">Liquidity and Going Concern</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">The Company has historically financed operations through cash flows from operations and equity transactions. Net cash used in operating activities was $<span id="xdx_905_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20220101__20221231_zNq7uYx86gob" title="Net cash used in operating activities">640,947</span> for the year ended December 31, 2022 compared to $<span id="xdx_906_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20210101__20211231_zebeZsUJtNr9" title="Net cash used in operating activities">1,583,138</span> for the year ended December 31, 2021. The $<span id="xdx_907_ecustom--DecreaseInNetOperatingLoss_iI_c20221231_z9FLAEHGUAT3" title="Decrease in net operating loss">942,191</span>, or 59.5%, decrease was primarily due to the decreased net operating loss. Net cash provided from financing activities was $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20221231_zOtxcMYFIOpl" title="Proceeds from the issuance of common stock">550,000</span> of proceeds from the issuance of common stock and $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfConvertiblePreferredStock_c20220101__20221231_zvlvpW7o9HX" title="Proceeds from the issuance of preferred stock">454,004</span> from the issuance of preferred stock compared to $<span id="xdx_90D_eus-gaap--ProceedsFromNotesPayable_c20210101__20211231_zyzuR8c6dJo7" title="Proceeds from notes payable">1,447,916</span> in proceeds from notes payable from Dole and $<span id="xdx_90F_ecustom--ProceedsFromEidlAndPppLoans_c20210101__20211231_zjYBKDfTxQ8c" title="Proceeds from EIDL and PPP Loans">133,395</span> in proceeds from the PPP loan and the EIDL in the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">As of December 31, 2022, the Company had $<span id="xdx_901_eus-gaap--CashAvailableForDistributions_iI_c20221231_zUnETkYehDH5" title="Operating cash">577,066</span> in operating cash and expects that operating cash flow net of contractual reimbursements and notes payable funding from Dole for the year ending December 31, 2023 will be approximately $<span id="xdx_90D_eus-gaap--OperatingCostsAndExpenses_c20220101__20221231_zWilThwlWaph" title="Estimated operating expenses, net">546,000</span>. Management believes that there may not be enough cash to pay our expenses for one year beyond the date of this report. Marketing of additional genes may lead to additional revenue and we have some flexibility to reduce operating costs but we may require additional capital. These factors create substantial doubt as to our ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that may result if the Company is unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:SubstantialDoubtAboutGoingConcernTextBlock> | |||||||||||||||||||||
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> -640947 </us-gaap:NetCashProvidedByUsedInOperatingActivities> | |||||||||||||||||||||
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> -1583138 </us-gaap:NetCashProvidedByUsedInOperatingActivities> | |||||||||||||||||||||
<fnam:DecreaseInNetOperatingLoss contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 942191 </fnam:DecreaseInNetOperatingLoss> | |||||||||||||||||||||
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 550000 </us-gaap:ProceedsFromIssuanceOfCommonStock> | |||||||||||||||||||||
<us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 454004 </us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock> | |||||||||||||||||||||
<us-gaap:ProceedsFromNotesPayable contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 1447916 </us-gaap:ProceedsFromNotesPayable> | |||||||||||||||||||||
<fnam:ProceedsFromEidlAndPppLoans contextRef="From2021-01-012021-12-31" decimals="0" unitRef="USD"> 133395 </fnam:ProceedsFromEidlAndPppLoans> | |||||||||||||||||||||
<us-gaap:CashAvailableForDistributions contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 577066 </us-gaap:CashAvailableForDistributions> | |||||||||||||||||||||
<us-gaap:OperatingCostsAndExpenses contextRef="From2022-01-01to2022-12-31" decimals="0" unitRef="USD"> 546000 </us-gaap:OperatingCostsAndExpenses> | |||||||||||||||||||||
<us-gaap:SubsequentEventsTextBlock contextRef="From2022-01-01to2022-12-31"> <p id="xdx_808_eus-gaap--SubsequentEventsTextBlock_zk7oNPhqQxVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Note 14: <span id="xdx_82B_zXMsTPujtDn5">Subsequent Event</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">During the year ended December 31, 2022, the Company filed forms 941-X for the quarters ending December 31, 2020, March 31, 2021, June 30, 2021 and September 30, 2021 and expects to receive refunds totaling $<span id="xdx_908_eus-gaap--IncomeTaxReceivable_iI_c20221231_z0bWVgWX20og" title="Employee retention credit">78,000</span>. Subsequent to December 31, 2022, the Company received a $<span id="xdx_901_eus-gaap--ProceedsFromIncomeTaxRefunds_c20230101__20230309__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1XvjTvDtKe8" title="Employee retention credit received">21,000</span> refund for the quarter ended September 30, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> </us-gaap:SubsequentEventsTextBlock> | |||||||||||||||||||||
<us-gaap:IncomeTaxReceivable contextRef="AsOf2022-12-31" decimals="0" unitRef="USD"> 78000 </us-gaap:IncomeTaxReceivable> | |||||||||||||||||||||
<us-gaap:ProceedsFromIncomeTaxRefunds contextRef="From2023-01-012023-03-09_us-gaap_SubsequentEventMember" decimals="0" unitRef="USD"> 21000 </us-gaap:ProceedsFromIncomeTaxRefunds> | |||||||||||||||||||||
</xbrl> |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/13/20 Evolutionary Genomics, Inc. 10-Q 9/30/20 57:30M Edgar Filing LLC/FA 3/30/20 Evolutionary Genomics, Inc. 10-K 12/31/19 61:4.4M Edgar Filing LLC/FA 4/01/19 Evolutionary Genomics, Inc. 10-K 12/31/18 61:29M Edgar Filing LLC/FA 3/05/18 Evolutionary Genomics, Inc. 10-K 12/31/17 59:3M Edgar Filing LLC/FA 2/10/17 Evolutionary Genomics, Inc. 10-K 12/31/16 66:3.8M Edgar Filing LLC/FA 2/25/16 Evolutionary Genomics, Inc. 8-K:3,5,9 2/22/16 3:136K Edgar Filing LLC/FA 10/23/15 Evolutionary Genomics, Inc. 8-K:2,3,4,510/19/15 7:265K Edgar Filing LLC/FA 7/02/15 Evolutionary Genomics, Inc. S-4/A 41:10M Edgar Filing LLC/FA 4/02/15 Evolutionary Genomics, Inc. S-4 36:3.3M Edgar Filing LLC/FA 3/05/15 Evolutionary Genomics, Inc. 10-K 12/31/14 35:2.1M Edgar Filing LLC/FA 9/23/10 Evolutionary Genomics, Inc. 10-12G 9/24/10 6:143K Precision Edgar/FA |